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ABSTRACT
MATERNAL MODULATION OF NEONATAL IMMUNITY
by
Omar R. Fagoaga

Although the neonatal immune system is functionally immature, immune
response capabilities are not the same in all newborns. The objective of this thesis was to
determine development of immunocompetence and test the hypothesis that activation of
maternal inflammatory immunity during pregnancy influences maturation of the neonatal
immune system.
Lymphocytes in blood and spleen were immunophenotyped by flow cytometric
analysis to determine differentiation characteristics, and splenocytes were assessed for
cytokine production capabilities. In normal Th2-prone outbred (CD-I) mice, an adult
repertoire of naive lymphocytes has developed by day 10 and memory cells by day 20, in
blood and spleen. However, in Thl-biased inbred (C57BL/6) mice, the development of
adult immunophenotypes is accelerated by five days. Adult Thl capability was
established in neonates as early as day 5. These findings indicate that neonatal immune
cells have the capability to produce adult-like responses, given an environment
demanding such immune reactions.
To test the hypothesis that inducing inflammatory Thl immune reactions in
pregnant CD-I outbred mice advances development of immune cell phenotypes and Thl
response predominance in progeny, dams were inoculated with Leishmania major
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antigen. As adults, experimental progeny had significantly lower numbers of circulating
T (naiVe and memory helper, and cytotoxic) cell phenotypes compared to that in control
cohorts, while spleens were populated with significantly greater numbers of T and natural
killer cells. Contrary to expectations, maternal inoculation led to suppression of Thl
cytokine production in offspring. Thus, developmental pattern of immune phenotypes
and Thl capabilities was Th2-biased in offspring. These data suggest that trafficking of
critical numbers of lymphocytes into blood and spleen, and development of a memory
cell repertoire, define maturation of immunocompetence and close the window of
immaturity. Results support the hypothesis that epigenetic factors (maternal immune
reactions during gestation) can modulate maturation of an immune cell repertoire and
development of cytokine response capabilities in offspring.

CHAPTER ONE
INTRODUCTION

Baby heart transplantation was founded at Loma Linda University
Medical Center in late 1984. Since then, more than two hundred twenty babies
have received new hearts before one year of age in the Pediatric Cardiac
Transplant Program. Most of these neonatal cardiac transplant recipients have
demonstrated mild alloreactivity (Nehlsen-Cannarella, 1991; Nehlsen-Cannarella
& Chang, 1992). A classic example is “Baby Paul” (Maclaren, 1994), delivered
at thirty-six weeks gestation by Cesarean section following an uneventful
pregnancy. Immediately given a heart transplant, Paul has grown and developed
normally for the past ten years, with a single low-dose immunosuppressive agent
as the only precautionary therapy. About half of neonatal transplant cases
exhibited one minor rejection episode within thirty days of transplant (Chiavarelli
et al., 1992), and very modest immunosuppressive therapies facilitate graft
acceptance and maintain adequate immunity to respond to life-threatening
infections (Bailey, 1991). Recalcitrant rejection (3 episodes <1 year
posttransplant) occurs in less than nine percent of recipients. Such severe
rejection in infants is rare, suggesting perinatal acquisition of heightened immune
function had occurred.
Many factors may account for the unexpected vigor of rejection, including
inadequate immunosuppressive therapy, mismatching of HLA and gender, genetic
background, and immunological events occurring during gestation (Nehlsen-Cannarella
& Chang, 1992). Of nine neonates that have died as result of uncontrollable graft
rejection, “Baby Olivia” was most notable (Klein, 1995). This 38-week fetus was
3

4

electively delivered by Cesarean section, received a transplant within a few hours of
birth, and died 2 weeks later of intractable cell-mediated graft rejection despite “heroic”
anti-rejection intervention. Neither infections nor other pathologies were apparent. With
what was known about the newborn “window of opportunity” for immunotolerance
(detailed below), this premature newborn should not have responded with such an
inflammatory rejection. After ruling out potential problems in donor medical condition,
donor heart status, and surgical procedure, Dr. Nehlsen-Cannarella, Clinical Transplant
Immunologist, suspected that a complication of the mother’s pregnancy may have
contributed to the baby’s aggressive immune response. In fact, Olivia’s mother had
suffered a pulmonary embolus at 20 weeks gestation and received daily heparin
injections. Initially these were of porcine extraction, but severe allergic reactions
mandated a switch to bovine heparin. Multiple cutaneous sites of maternal tissue damage
observed in the postpartum period corroborated the mother’s report of persistent allergic
reactivity to substituted bovine protein. This led Nehlsen-Cannarella to formulate the
hypothesis that significant, prolonged activation of maternal immune system influenced
the rate of fetal immune development. This and other such notable exceptions to
expected allograft acceptance provided a principal motivation for this research proposal.
Sustained success in baby heart transplantation (1-year graft survival rate >90%
when allograft recipients were 2-3 weeks old) may actually depend on immaturity of
neonatal immunity (Bailey et al., 1985). Although purely anecdotal, experience gained
by the LLUMC team in maintaining pretransplant neonates in protected versus immunechallenging environments suggests that posttransplant management may facilitate
allograft acceptance (Bailey et al., 1985; Bailey, 1991; Kurtzhals et al., 1994). This
clinical experience is analogous to reports in small animal models (Burgio et al., 1990;
Clerici, et a/., 1993; Dudley & Wiedmeier, 1991) where exposure to foreign antigens
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immediately after birth drives aggressive immune responses and prematurely builds an
inflammatory memory repertoire. However, some neonates, like Baby Olivia, have
demonstrated adult-like graft alloreactivity within a few days of birth after receiving a
graft with the same or less mismatched antigens as those of other infants. These findings
raise the possibility the perinatal immune system may be modulated by the maternal
immune activity during gestation. Lessons from neonatal transplant patients in which
highly aggressive immune reactivity was evident suggest that the “window of
opportunity” for graft tolerance may have prematurely “closed.”

Neonatal immune capability
While allotransplantation of adult stem cells causes morbidity and mortality in
bone marrow transplant recipients, neonatal cord blood cells elicit a lower incidence and
lessened severity of graft-versus-host disease (Broxmeyer et al., 1989). Cord blood is
highly enriched in naive T helper cells, those with cluster of differentiation (CD) markers
CD3CD4CD45RA (Bradley, et al., 1989). These cells induce suppressor activity in T
cytotoxic/suppressor (CD3CD8) lymphocytes (Morimoto et al., 1985). Such natural
suppressor cells are antigen nonspecific, major histocompatibility complex (MHC)
unrestricted, and are present in fetal and newborn lymphoid tissues and liver (Hoskin et
al., 1983; Oseroff et al., 1984; Hooper et al., 1986; Jadus & Peck, 1986; Maier & Holda,
1987). Han et al. (1995) determined that cord blood lymphocytes are mainly immature,
unprimed T suppressor cells that likely favor non-inflammatory rather than aggressive
inflammatory activity.
By contrast, inflammatory activity is the result of a subset of T helper
lymphocytes called T helper 1 (Thl) cells, while non-inflammatory activity is directed by
another subset, Th2 cells (Wegmann et al., 1993). Thl activity is associated with
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secretion of cytokines interleukin-2 (IL-2), tumor necrosis factor alpha (TNFa) and
interferon gamma (IFNy) (Krishnan et al, 1996b) while Th2 activity is associated with
secretion of IL-4, IL-5, and IL-10 (Krishnan et al, 1996a). Han et al. (1995) have shown
that cord blood T suppressor cells express receptors for IL-2 and TNFa, but not IL-1, a
pro-inflammatory cytokine (Kuby 1994). In addition, cord blood natural killer (NK) cells
(a nonspecific cytotoxic cell of innate immune system) express TNFa receptor (R),
IFNyR and IL-2R(3-chain, but not IL-1R or IL-2Ra-chains.
When expressing these receptors, immature T and NK cells are likely to be
influenced by these cytokines, but significant concentrations of suppressor cells in cord
blood have been shown to tip the balance in favor of non-inflammatory rather than
aggressive inflammatory activity (Han et al., 1995). In vitro, only Th2 responses are
induced in stimulated neonatal T cells. In contrast to mature immune reactions, IL-4, a
Th2 cytokine, stimulates naive neonatal T cells to produce IFNy. Although a Thl
cytokine, IFNy is produced if naive neonatal cells are in the resting state and this
stimulates Th2 responses in the natural suppressor cells (Maier et al., 1985; Holda, 1986;
Maier et al, 1986; Wu et al., 1994). Additionally, the effects of cytokines acting in
admixture are distinct from those observed when acting separately. By example, IL-4
and IL-12 together induce naive cells to produce IL-4 and IFNy, rather than IL-4 and IL5, as would be expected from cells of older individuals. Thus, evidence suggests both
Th2 and Thl cytokines activate predominantly Th2 responses in neonatal T cells, hence
extending the non-aggressive gestational immune status beyond birth. Information like
this illustrates one of the reasons why clinical experience, as in Baby Olivia’s case, is so
perplexing. It had been expected that Olivia would have predominantly Th2 responses,
instead she responded to transplantation with strong inflammatory Thl reactions.
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Immune system development during the perinatal period: immune cell phenotypes
Specific lymphocyte subsets in circulation and secondary lymphoid organs define
host defense capabilities and status of immune activity in adulthood (Barclay et al., 1997;
Bikoue et al., 1997). With respect to expression of CD markers, different lineages or
maturational stages of leukocytes can be distinguished by their expression of membrane
molecules recognized by particular monoclonal antibodies. However, much less is
known about lymphocyte phenotype populations and their trafficking during the neonatal
period. Such information is required to understand acquisition of immune response
capabilities during development.
In human, few T cells are present in umbilical blood compared to that in five-dayold neonates or adults (Pittard et al., 1989; Raes et al., 1993). Compared to later ages,
neonates have reduced numbers of lymphocytes that express CDS (pan T cell marker),
CD3CD4 (T helpers), CD3CD8 (T cytotoxic/suppressors), CDS (T and a subset of B
cells), CD3CD4CD45RO (T memory cells) and CD25 (low-affmity receptor for IL-2)
(Pittard et al., 1989; Han et al., 1995). Additionally, the number of naive T cells is
increased ten-fold in newborns over that in adults (Raes et al., 1993; Han et al., 1995). In
early childhood, T helper/inducer, memory T helper, T cytotoxic/suppressor, CD5positive B cells, and immunoglobulin secreting B cells increase rapidly to supercede
those found in adults (Nahmias et al., 1994). The fewer numbers of differentiated and
activated lymphocyte subsets found in the developing immune system of neonates and
young infants, however, suggest immaturity in Thl-type inflammatory response
capabilities.
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Maturation of immunophenotype proportions and numbers in the human is not
fully understood because data are very limited during the postnatal period. Memory cell
number and differentiation, an important aspect of immune system function, has yet to be
studied during the neonatal period of humans. Expression of the lymphocyte homing
receptor (CD44) has been found early in prothymocyte immigrants and throughout
maturation of T lymphocytes in lymph nodes as early as 12-14 weeks gestation. This
expression in humans is analogous to the murine Pgp-1 molecule of prothymocytes and
mature T cells (Horst et al., 1990). However, in mouse, up-regulation of this molecule by
T cells is indicative of memory/effector development (DeGrendele et al., 1997).
Upregulation of CD44 on T cells has been studied only in context of antigen-specific
responses by adult T cells; there are no reports about CD44 up-regulated expression
during normal neonatal development. Definition of the temporal pattern of appearance of
various lymphocyte immunophenotypes, especially memory cells, should help
characterize maturation of full response capabilities in the neonatal subject.
In mouse, down-regulation of lymph node homing receptor CD62 ligand
(CD62L) is also associated with naive-to-memory conversion. In murine thymus at 14
days gestation, thymic immigrants express high levels of CD62L; thereafter, most
cortical thymocytes express this phenotype (Reichert et al., 1986). A dramatic increase
in numbers of thymocytes expressing high levels of CD62L (CD62Lhlgh) occurs between
birth and 4 weeks of age. However, after encountering an antigen, expression of CD62L
by recent thymic emigrants is down-regulated (CD62Llow) or eliminated. Further, a
decrease in number of cells co-expressing CD62L and CD44 in spleen and lymph nodes
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during senescence correlates with increased incidence of infection (Barrat et al., 1995). It
is conceivable that small numbers of these same cells (CD44hlgh) are present during the
neonatal period that could, in part, explain increased incidence of infections associated
with this age. Because the developmental profile of mature phenotypes is not yet
defined, an objective of this work was to define the maturation profile of
immunophenotypes to determine the basis for acquisition of immunocompetence.
Several studies in the mouse have focused on immunophenotype maturation but,
again, the earliest neonatal ages have not been studied. In terms of magnitude of T cell
proliferative reactions, the newborn mouse appears comparable to a 12-week-old human
fetus (Mosier et al., 1977a). By postnatal day 35, total B cell proportions in mice have
attained adult levels some 3 weeks in advance of T cell numbers (King et al, 1991).
With respect to T cell markers, proportions of splenocytes expressing Thy 1.2 (a pan T
cell marker in mouse, equivalent to CD3 in human), CD4, CD5, and CDS increase from
day 5 to adulthood (King et al, 1991). Similarly, in germ-free and specific-pathogenfree mice, adult-like numbers and proportions of T helper, T cytotoxic and B cells are
reached in the spleen between postnatal days 14 and 21 (Fomi et al, 1988). This
observation in relatively non-challenged mice raises the possibility that increases in
splenic lymphocytes may not be solely driven by pathogenic stimulation. Whether
immunocompetence is achieved by cell trafficking, cell proliferation, changes in subset
proportions, or cell subtype maturation (such as memory cell differentiation) has not been
determined and is a focus of this thesis.
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Immune system development during the perinatal period: functional capabilities
The immune system of the neonate is functionally immature. As discussed
earlier, human cord blood stem cells elicit a reduced incidence and less severe graftversus-host disease relative to those responses of adults (Beck et al., 1994). Cord blood
is highly enriched in naive T helper (Raes et al., 1993) and T cytotoxic/suppressor cells
expressing enhanced suppressor activity (natural suppressor cells; Morimoto et al., 1985).
In mouse, natural suppressor cells are antigen non-specific, MHC unrestricted and
present in lymphoid tissues and liver of fetus and newborn (Scollay & Shortman, 1984;
Osseroff et al., 1984; Koga et al., 1985; Maier & Holda, 1987; Fowell et al., 1998). In
humans a full complement of B cell subsets is also not yet developed in the neonate, a
finding attributed to absence of in utero exposure to antigen (Gathings et al., 1981;
Yamaguchi et al., 1983; Cooper, 1987; Timens et al., 1989; Burgio et al., 1990), a
condition also seen in the murine neonate (Hardy & Hayakawa, 1991).
Maturation of a complete repertoire of humoral responses in man is normally
achieved by five years of age (Cooper, 1987; Gathings et al., 1981). This delayed
development is thought to contribute to a higher susceptibility of infants and young
children to infection (Timens et al., 1989). Antibody production is relatively low
compared to that in adulthood, a likely consequence of a delay in appropriate B cell
subset development due to absence of antigenic stimulation in utero (Mosier et al.,
1977b). Neonatal B cells are able to produce IgGj and IgG3 (Burgio et al., 1990). IgG2
responses to polysaccharides are blunted in the infant compared to that in adulthood,
potentially interfering with effectiveness of neonatal vaccination. However, this
immaturity is supplemented by maternal immune components transferred to the fetus
(transplacental) and newborn (transmammary).
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Antigen presenting cell function appears to be a separate developmental process
in acquisition of immunocompetence during the perinatal period. In humans, dendritic
and myeloid cell populations appear in yolk sac at six weeks gestation and, by term,
migrate to primary and secondary lymphoid tissues (Beelen, 1990). These MHC class II
(HLA-DR)-expressing cells reside mainly in thymic medulla, with non-expressing cells
in cortex. Phenotypic characteristics of the neonatal macrophage are similar to those in
adults except lower densities of class II antigens are expressed and, subsequently, antigen
presentation is less efficient. In contrast, neonatal monocytes express high densities of
class II antigens relative to those from adults (McMaster et al., 1992). Neonatal
monocytes are significantly more efficient in presenting antigen (van Tol et al., 1984b),
and require a 100-fold lower dose of antigen than adult monocytes (van Tol et al., 1983;
1984b). Phagocytic and oxidative burst functions of myeloid cells in response to most
microbes are independent of age (Burgio et al., 1990), although response to group B
streptococcus is reduced (Burgio et al., 1990). Cytokine production (IL-1, TNF,
lymphotoxin and IFNa) by these cells is comparable to that of adults (Burgio et al.,
1990). Like the macrophage, dendritic cells in human cord blood are inefficient
accessory cells for T cell mitogen responses and poor stimulators in mixed lymphocyte
reactions. These are a reflection of significantly low expression of intercellular adhesion
molecule (ICAM-1) and MHC antigens as compared to that of adult cells (Hunt, et al..
1994).
Development of functional capabilities by murine T lymphocytes follow a pattern
seemingly parallel to appearance of specific immunophenotypes. As reviewed by Mosier
and Cohen (1975), murine thymocyte proliferative activity in responses to mitogens
(PHA and ConA) and alloantigens do not mature before the third week after birth.
Proliferative responses by splenic T and B cells are also not fully developed until 3-4
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weeks of age. Capacity for T cell-dependent antibody production is not achieved until 6
weeks of age, suggesting immaturity of T helper cell functional capabilities (such as
cytokine support), inadequate numbers, or both, during this developmental period.
Neonatal splenic T cells actually suppress adult T cell function.
Functional capacity of murine lymphocytes follows a specific developmental
pattern. Adkins et al. (1993) found that neonatal T cell production of cytokines in vitro
favors the Th2 non-inflammatory immune profile (IL-4, 5, 10). In contrast, the Thl
profile predominates in adulthood (IL-2, IFN-y, TNFa). T cells from 4-day-old neonatal
mice in culture with syngeneic adult antigen presenting cells (APC) produced nearly five
fold the amount of IL-4 than that made by adults; this capacity diminishes to adult levels
by day 6. Importantly, neonatal T cell production of Thl cytokines, IL-2 and IFNy, was
less than 5% of that by adults. Adult production capabilities required up to 45 days to
mature. These data suggest, however, that type and age of the accessory (APC) cell
cooperating with neonatal T cells may alter helper-lymphocyte function. Reports of
neonatal APC function are controversial (neonatal APC do not function appropriately,
Adkins et al., 1993 versus neonatal APC are superior to adult cells, van Tol et al, 1983;
1984a), and the bias of neonatal T cells to relate to neonatal APC is a focus of this work.
Overall, the perinatal immune system of both mouse and man can best be described as
immature but not inactive. Partial assessment of the capacity of murine APC to provide
appropriate signals to T cells during development is a focus of this thesis work.

Th2 responses characterize the fetal-maternal immune relationship in pregnancy
Studies have focused on the maternal mechanisms that allow for (a) tolerance of a
fetal hemi-allograft, z.e., fetus is viewed as a transplant (Stimson, 1983; Tomasi, 1983), or
(b) immune evasion, i.e., fetus is viewed as a tumor (Colbem & Main, 1991). During
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pregnancy, fetal and maternal immune systems favor active suppression and inhibition of
aggressive immune functions (Papadogiannakis et al., 1990; Claman, 1993a). From
studies of local tissue (uteroplacental region), peripheral circulation and lymphoid tissue,
the maternal immune system appears to be suppressed during gestation. Although
susceptibility to infections during pregnancy may be enhanced as a result of this immune
system depression, (Arsenis & McDonnell, 1989), the maternal immune system can
mount appropriate immune responses to most pathogens (Claman, 1993b).
A bias against maternal Thl responses during pregnancy has been proposed
(Howard et al, 1980; Wegmann et al, 1993; Krishnan et al, 1996a; Vince & Johnson,
1996) to protect the fetus from host-ver^w^-graft rejection. Rather, predominance of
placental Th2-like cytokines (IL-4, 5, 10) occurs throughout gestation while IFNy, a Thl
response, is found only in early gestation in relationship to implantation (Lin et al,
1993). These cytokine profiles may direct maternal immune activation towards Th2
cellular differentiation and reduce the risk of Thl cell-mediated cytotoxic activity against
placenta and fetus. This concept may explain why pre-term and term neonates accept
alloantigens to greater extent than older babies (Nehlsen-Cannarella & Chang, 1992). In
all, natural immunosuppression seems to characterize perinatal responses to alloantigens.
Evidence also suggests that activation of aggressive maternal Thl responses is
incompatible with successful delivery of viable offspring. Krishnan et al (1996a)
demonstrated that splenocytes and lymph node cells of pregnant mice infected with
Leishmania major have a decreased capacity to produce IFNy compared to non-pregnant
controls when stimulated in vitro. Additionally, after L. major infection, a decline in
placental IL-10 production and an increase in IL-2 and IFNy (Thl cytokines) occurs,
resulting in a 20% increase in fetal resorption (Krishnan et al, 1996b). Thus, a Th2
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domination in both maternal and fetal immune systems appears to be required for a
successful pregnancy.
Neonatal immune switch from Th2 to Thl immunity
Although the fetal immune system near term has developed some components of a
mature system, active immunosuppression maintains survival of the hemi-allograft in the
mature maternal immune environment. Effects of this pregnancy-induced
immunosuppression appear to extend postnatally and, as already mentioned, this extension
may create a “window of opportunity” for transplantation or tolerance induction (NehlsenCannarella & Chang, 1992). This window gradually disappears, an event apparently
paralleling the switch from Th2- to Thl-dominant immunity. Switching may be driven by
one of at least two mechanisms: either the host is reacting to, and developing memory for,
newly encountered antigens (Nevard et al., 1990), or natural production of predominantly
Thl-type cells may be governed by an internal clock. Either mechanism is likely to be
directed by prevailing cytokines and the changing hormonal milieu.
In experiments designed to elucidate the potential influence of cytokines on
lymphocyte maturation (Wu et al., 1994), human neonatal T cells were stimulated in
culture with mitogens and various combinations of cytokines. As a result, neonatal cells
were polarized to either Thl or Th2 phenotype, and cell phenotypes (naiVe versus memory)
reflected prevailing cytokine type. Moreover, the stimulation of neonatal cells by CD3
antibody in the presence of either IL-2, IL-4 or IFNy leads to an alteration in cytokine
profile produced by these cells when re-challenged. IL-12 is another cytokine recently
implicated in the Thl-Th2 paradigm. Differentiation of naive T (ThO) cells to Thl status
(Seder et al., 1993) is a process mediated by IL-12 which, in turn, induces IFNy production
by these cells. Thus, neonatal cells may differentiate into either Thl or Th2 subtype, a
process that results from directions given by cytokines, accessory cells, and antigenic
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stimulation. It is conceivable that exposure to inflammatory immune products could tilt
the Th2>Thl balance of gestation away from Th2 dominance by prematurely inducing Thl
maturation.
The perinatal immune system can best be described as immature but not inactive.
The importance of environment (external to body, and microenvironment of cells) in the
induction of T helper responses is emphasized in a recent study by Ridge et al. (1996).
Their study showed that neonatal murine T cells can be primed to produce Thl cytotoxic
activity at levels equivalent to that of adult T cells. Forsthuber et al. (1996) also found the
type of stimulation, and not stage of development, is what determines whether a response
is induced. Pennisi (1996) have stated that “All you have to do is put them [neonatal T
cells] in the right environment.” Induction of tolerance or aggression is regulated by the
dose and form of antigen presented (Oliff et al, 1981; Robbins et al, 1995; Sarzotti et al,
1996). Activated APC and co-stimulatory factors (cytokines, adhesion molecules) are
required to educate neonatal T cells; scarcity of either component leads to tolerance by
neonatal (and even adult) T cells (Oliff et al, 1981; Robbins et al, 1995; Sarzotti et al,
1996). Thus, enriched numbers of activated relevant antigen presenting cells could signal
closure of the “window of opportunity.” Acquisition of Thl capabilities may be naturally
delayed to allow for successful delivery of a neonate.
The fetus is a transplant of tissue half unlike the mother bearing it, except in
inbred animals. How does a fetus develop immunocompetence without subsequently
rejecting its mother? Clinical observations in humans indicate the perinatal immune
system favors tolerance rather than rejection of alloantigens, that is, a predominance of
Th2-mediated responses (Brugg et al, 1995). Such an environment during this time
represents a chronological “window of opportunity” that can be exploited for inducing
acceptance of organ transplants (Beer et al, 1977). Tolerance is principally mediated by
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Th2 lymphocytes while rejection results from enhanced activity by Thl (Chen & Field,
1995). While perinatal T lymphocytes can be induced to produce an effective in vitro
inflammatory Thl immune response, in vivo inflammatory reactions are not apparently
common in the neonate. In fact, little is known about the mechanism leading to
differentiation of either an inflammatory or tolerogenic response by T helper cells during
immune maturation.
There is other evidence of environmental factors mediating development of the
perinatal immune system. Transvaginal or intrauterine infection, a major concern for
initiating pre-term labor, is associated with enhanced activity in the fetal immune system.
In newborns in which premature labor occurred with intact membranes, Berry et al.
(1995) found increased numbers of activated fetal monocytes. Whether such effects on
newborn monocytes were mediated by enhanced cytokine production by maternal
immune activity crossing the placenta, or by direct fetal response to an offending
pathogen entering its environment, could not be discerned.
However, transvaginal microbial invasion of the amniotic cavity, a significant
mediator of perinatal immune activity, may not account for all advanced development of
neonatal immune systems. It is proposed here that activation of inflammatory reactions
in the maternal immune system in response to antigens may be a major mediator of fetal
immune system development. Further, such immunoreactivity may be instrumental in
preparing the fetus for life outside the womb beyond that which is afforded through
transplacental transfer of IgG antibodies alone.
Maternal antibodies in fetus and newborn
Another important aspect of perinatal immune development is humoral immunity.
Maternal and infant antibody production are well studied. An extensive literature
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supports the observation that maternal immunoglobulin G (IgG) is actively transported
across the placenta, although the transport mechanism is only partially understood (Malek
et al, 1996). All four IgG subclasses are present in fetal circulation during the third
trimester; concentrations for some are greater than that found in maternal circulation and
suggest, in particular, preferential transport of IgGj. Moreover, passive immunity is
provided to the neonate through breast milk. All immunoglobulin isotypes (IgG, IgA,
IgM, IgD, IgE) are found in human milk (Newman, 1995). Human milk and colostrum
contain leukocytes that defend against invading pathogens; these are 50% neutrophils,
40% macrophages, and 10% lymphocytes (1:4, B:T cells, respectively). In rodents as
well, maternal antibodies are recognized to cross the placenta into fetal circulation and
persist in the neonate (Newman, 1995; Lemke et al., 1994). IgM and IgG responses to
antigenic challenge are reported to occur in newborn and 6-week-old mice, but are
significantly reduced compared to those of adults, being deficient in isotypes and
specificities. The maternal immune system is recognized to influence development of
antibody specificities during the perinatal period. Immunoglobulins do not regulate
development of cell-mediated immunity and are not a focus of this dissertation.

Immunomodulation ofperinatal immunity
Development of the neonatal antibody repertoire is influenced by maternal
antibody transport, a phenomenon that may last a lifetime and extends its influence as far
as FI and F2 progeny (Lemke et al, 1994). Allotype and idiotype expression of
immunoglobulin genes are enhanced during fetal immune development by maternally
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transferred antibodies (Mage, 1975; Homg et al, 1980). In addition, maternal anti
idiotype antibodies, entering fetal circulation, down-regulate production of specific
idiotypes produced by the offspring (Lemke et al, 1994). Of particular concern is the
transplacental transfer of maternal IgG antibodies directed to inherited paternal antigens
(Nehlsen-Cannarella & Chang, 1992) (a phenomenon denied by some; Claman, 1993),
which can be found throughout fetal tissues (Adeniyi-Jones & Ozato, 1987). These
antibodies have the potential of being deleterious to fetal well-being. Circulating
maternal antibodies also interfere with development of immune responses to vaccines
(Albrecht et al, 1977; Mosier et al, 1977b; Harte et al, 1982; Swartz et al, 1989; Zhang
& Mille, 1993; Linder et al, 1995). (This, in part, may be a consequence of tolerance by
nai've B cells.) Thus, transport of maternal antibodies into fetal circulation serves to
transfer maternal immune information to the fetus and neonate.
Challenges of the maternal immune system during, and even before, pregnancy
have been shown to be capable of modulating neonatal immune responses. Recent data
suggest that this modulation is mediated by T helper cells. Following maternal Th2
immunization (SRBC) on day 10 of gestation, offspring challenged with SRBC at six
weeks of age had significantly reduce IgM and IgG responses (Fujii & Yamaguchi,
1992). These authors demonstrated that when immunization with a conjugate of
pneumococcal type 9V polysaccharide and tetanus toxoid induced a Thl-dependent
antibody response, not only were isotype switching and maternal anamnesia induced but,
more significantly, IgM levels in fetal circulation were increased. Since IgM does not
cross the placenta, resulting increases in fetal IgM antibody titers (Lu et al, 1994) could
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only be of fetal origin. Perhaps the temporal advancement in isotype switching witnessed
in these experiments is the result of maternal soluble factors (cytokines) crossing the
placenta. The porosity of the placenta to maternal immune components has been the
focus of studies of fetal sensitization to antigens eliciting maternal immune responses
during gestation.
Immune challenges occurring during pregnancy can result in modulation of
neonatal cell-mediated immunity. Several investigators (Field & Caspary, 1971; Cramer
et al., 1974; Russell, 1975) have demonstrated neonatal immunity to antigens recognized
by the maternal immune system before conception or during pregnancy. They have
proposed such explanations as transplacental passage of antigen, transfer factor,
antibodies, and sensitized maternal cells, leading to active sensitization of the neonate. It
would be teleologically advantageous to the offspring to enter its new (the mother’s)
environment immunized to the pathogens it will encounter, a condition only partially
fulfilled by passively acquired (maternal) antibody.
The mechanism for fetal sensitization has been proposed to be a result of maternal
cell passage, vertical antigen transmission, or maternal transfer of soluble factors. Cell
traffic across the placenta has been well documented. In humans, maternal myeloid and
lymphoid cell passage has been reported either by empirical data in umbilical cord blood
evaluations (Desai & Creger, 1965) and in patients suffering from severe combined
immunodeficiency (Pollack et al., 1982), or by inference through evaluations of neonatal
sensitization (Russell et al., 1975). In mouse, maternal immune cell passage has been
inferred (Beer et al, 1977) and, recently, observed (Piotrowski & Croy, 1996). Vertical
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transmission of antigens, however, appears to be a viable alternative explanation for fetal
sensitization to maternal antigens (Stastny, 1965). Horton & Oppenheim (1976)
demonstrated newborn T cell sensitization, i. e., cell-mediated immunity, to dental plaque
antigens found in mothers experiencing periodontal disease during their pregnancy and
concluded this occurred as a result of vertical transmission of antigen. Yet others
(Bametson et al, 1976) have proposed presence of a soluble lymphocyte factor by
demonstration of sensitization to Mycobacterium leprae in newborn of infected mothers.
Therefore, one would expect variations in newborn immunity to result from maternal
modulation of the neonatal immune system. Although, we cannot test this in humans,
stimulation of the neonatal immune system following maternal exposure to an immune
challenge in the murine model is the objective of Specific Aim #3.
Maternally-derived cytokines are potential candidates for modulating fetal and,
subsequently, neonatal immunity. Placental cytokines serve a variety of functions (Lin et
al., 1993; Wegmann et al., 1993) including modulation of immune function of the
developing fetus. Cytokines stimulate placental cell growth and improve fetal survival
(Wegmann, 1984; Athanassakis et al., 1987), and when released in response to
endotoxin, induce fetal growth retardation, skeletal malformations, neuronal necrosis, and
abortion through placental ischemia (Reul et al., 1994; Chaouat et al., 1995).
Inflammatory mediators, such as IL-1, are also found surrounding the embryo just before
successful implantation (McMaster et al., 1992). These observations serve to illustrate
the pluripotential actions of cytokines.
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The placental barrier to cytokines appears to be selective. Granulocyte colonystimulating factor readily passes the uteroplacental barrier (Medlock et ai, 1993) while
others such as IL-8 (Reisenberger et al., 1996) and erythropoietin (Koury et al, 1988) do
not. Although effects of transplacental passage of cytokines on fetal immune function
are clearly possible, it is known that cytokines do not convey antigen-specific
information that could direct antigen-specific perinatal host immunity. A thorough
review of the role that maternal cytokines may have in modulating perinatal immunity is
beyond the scope of this work. However, experiments in the murine model focus on the
importance of cytokine production as an index of the switch from Th2 to Thl immunity
during the neonatal period.

Maternal cell transfer to the fetus
Transfer of maternal cells to the offspring may be another mechanism for
modulating neonatal response capabilities. Passage of maternal cells into fetal circulation
has been documented as normal occurrences in human and animal pregnancies (Desai &
Greger, 1963; Piotrowski & Croy, 1996). Maternal lymphoid cells naturally enter the
allogeneic fetus and take up residency in specific lymphoid organs (Beer et al., 1977;
Collins et al., 1980; Fujii & Yamaguchi, 1992; Piotrowski & Croy, 1996). Passage of
maternal cells into the fetus could explain observed B cell unresponsiveness to
noninherited maternal HLA specificities documented in adults that are otherwise highly
reactive to alloantigens (Claas et al., 1988). An early study by Hunziker et al, (1984)
failed to find maternal cells in neonatal liver. However, the authors acknowledged their
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methods were relatively insensitive (1x10^ cells was the limit of sensitivity) and concerns
were raised about validity of the technology used to track maternal cells in vivo. An
elegant study by Piotrowski and Croy (1996) has since demonstrated that maternal cells
are found in most fetal tissues, in neonatal lymphoid organs including liver, spleen, and
bone marrow of SCID mice, and in bone marrow of wild type mice. Findings of this
study indicate that maternal cells, transiting the uteroplacental interface, could directly
convey information to the offspring about pathogens in the environment.
Transfer of maternal cell-mediated immunity (activated maternal lymphocytes
crossing the placenta) might be a means the mother uses to protect her offspring when
conditions in her immediate environment demand more than an antibody response. Of
special interest in this regard is the study by Beer et al. (1977) in which Fisher rats were
made chimeric through cyclophosphamide treatment and total lymphoid replacement
with Lewis rat bone marrow cells. When these chimeric females were mated with
unaltered Fisher males, at least 57% of the infants developed runt disease. The nonrunted offspring were tolerant of Lewis rat skin grafts. Graft-versws-host (runt) disease
was most common in male progeny, although some dose-dependency was evident. Of
special note was the observation that sensitized (anti-Fisher rat) Lewis cells were more
aggressive than naive donors in inducing the disease. These findings raise the possibility
that activated immune cells might either indirectly convey information to the offspring
(by cytokines) or cross the placenta to directly educate the fetal immune system.
Recently, Hunt et al. (1994) provided a compelling raison-d’etre for why neither
maternal nor fetal immunocompetent cells should survive active passage across the utero
placental interface, the Fas ligand-mediated apoptotic barrier. Of specific interest to the
present proposal is these authors were able to demonstrate Fas ligand message and Fas
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protein are at their lowest levels in placenta near term. During this period of
development, maternal cells have the greatest opportunity to cross the placenta. Thus, it
is possible that infiltrating maternal cells could up-regulate fetal lymphocytes and
advance maturation of fetal immunity.
However, evidence suggests that, to secure the fetus from maternal immune
aggression, barriers within the uterus create an immunologically privileged site (Streilein,
1993; Griffith et al, 1995). One fetal membrane, the chorion, is a non-junctional single
cell layer that allows only small solutes to pass. The chorion does not extend into the
placenta, the major maternal-fetal interface. Many cell types are present in placenta.
Here cytotrophoblasts and related tissues of fetal origin express classical HLA molecules
(Claman, 1993a) and have the ability to serve as an immunoabsorbent barrier to maternal
anti-paternal HLA antibody (Reed et al, 1991), while they are absent from
syncytiotrophoblasts. In the fetus, significant levels of soluble HLA circulate where they
can neutralize maternal antibodies and cytotoxic T lymphocytes directed to paternal
specificities (Riisswurm et al, 1998). However, in some pathological conditions
maternal cell transfer has been implicated.
In disease states, maternal cells have been recognized in fetal tissue (Kadowaki et
al, 1965; Cederbaum et al., 1972; Collins et al., 1980; Pollack et al., 1982; Geha &
Reinherz, 1983). Transplacental hemorrhage also allows for passive exchange of blood
constituents, as the placenta separates from uterine tissue at parturition (Benirschke &
Kaufman, 1995). Thus, in a variety of instances maternal cells have been shown to cross
the placenta into fetal circulation. For the present proposal, search for maternal cells in
the neonate is beyond the scope of this investigation.
Proposed studies
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Based on observed variation in neonatal immunities, the working hypothesis of
this thesis is postnatal immune system capabilities are defined by the profile of
immunophenotypes and modulated by maternal immune activity during gestation. More
specifically, that induction of maternal T helper 1 immune responses during gestation
modulate patterns of fetal immune development (cell phenotypes and cytokine response
capabilities^ This dissertation is focused on the following aims:

1.

To establish the developmental pattern (from birth to adulthood) of normal
immune cell phenotypes in CD-I mice, a genetically wild-type strain that
represents the usual non-inflammatory, basal (Th2-prone) immune system of
outbred populations. This specific aim also tests the hypothesis that the
attainment of an adult-like repertoire of immune cells (particularly T helper
memory cells) closes the neonatal window of immaturity (Chapter 3).

2.

To establish the developmental pattern of immune cell phenotypes in
C57BL/6 (a T helper 1-prone mouse strain) from birth to adulthood, and to
test the hypothesis that Thl-dominant individuals experience an
advancement in their immune development (Chapter 3).

3.

To establish the maturational pattern of cytokine response capabilities from
birth to adulthood, and to test the hypothesis that reported neonatal Th2 bias
is the result of an artificially contrived experimental paradigm (Chapter 4).
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4.

To test the hypothesis that maternal immune reactions during gestation
influence the pattern of immune development (cell phenotypes and cytokine
response capabilities) in offspring (Chapter 5).

Structure of dissertation
Each of the specific aims addressed maturation processes of the immune system.
In Specific Aim #1, the main objective was to establish developmental profiles of cell
phenotypes in blood and spleen of individuals possessing normal, non-aggressive
(defaults to Th2) immune characteristics {Le., an outbred specie). Advent of sensitive
technology (flow cytometry) and availability of specific reagents (monoclonal antibodies)
provided the means to address gaps in the current literature. This study established, in a
mouse model, patterns of early lymphocyte differentiation taking place during the first
postnatal week. To date, very little is documented regarding the process and timetable of
thymic exportation and population of splenic lymphoid compartments. Furthermore,
differentiation profiles of naive and memory T helper cells, phenotypes responsible for
translating directives from antigen presenting cells for induction of tolerance or rejection,
have not been studied during the most critical first days of neonatal mouse. Thus, the
objective of the present study was to determine developmental patterns with respect to
proportions and absolute numbers of select lymphocyte subsets in blood and spleen from
birth to adulthood. Neonatal lymphocytes were critically evaluated to test the hypothesis
that attainment of an adult-like repertoire of immunophenotypes and T helper memory
cell differentiation contributes to closure of the neonatal window of immaturity.
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Parameters measured in testing the hypothesis of Specific Aim #1 included total
leukocytes (WBC), total lymphocytes, and multiple lymphocyte subpopulations
distinguished by their expression of specific membrane molecules, “CD markers.” Data
of this evaluation are presented in CHAPTER 3, and discussed in CHAPTER 6.

In Specific Aim #2, the objective was to test the hypothesis that young Thlprone individuals have experienced an advancement of their immune development.
This concept was partially addressed by comparing the development of immune cell
phenotypes of neonatal Th2-prone (CD-I outbred) to Thl-prone (C57BL/6 inbred) mice.
Parameters measured in testing the hypothesis of Specific Aim #2 are the same as for
Specific Aim #1. Proportions and absolute numbers of these cells were enumerated in
whole blood and spleen of both strains of mice. Data of these evaluations are presented
in CHAPTER 3 and discussed in CHAPTER 6.
The objective of Specific Aim #3 was to establish the postnatal ontogenic
profile of cytokine production at various ages. Further, experiments in Specific Aim
#3 test the hypothesis that the reported bias of neonatal T cells to selectively produce
Th2 cytokines is the result of an artificially contrived experimental paradigm.
Approaches used to test the hypothesis included qualitative and quantitative assessment
of cytokines [IL-4 (Th2); and IL-2 and IFN-y (Thl) produced in response to alloantigen
(pooled spleen cells of allogeneic mice) and polyclonal (CD3 ligation) stimulation. A
significant modification of the experimental paradigm of Adkins et al. (1993) was
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introduced in the current work, designed to avoid erroneous interpretation of
experimental outcomes.
The objective of Specific Aim #4 was to test the hypothesis that Thl-type
immune events experienced by the mother during gestation can modulate the
pattern of immune development (cell phenotypes and cytokine response capabilities)
in offspring. To test this hypothesis, pregnant dams received an injection of Leishmania
major extract (protozoa killed by sonication), and pups were studied for the same
parameters as outlined above (unchallenged mice). Specific sensitization of pups was
tested in vitro using a “memory recall” protocol (spleen cells challenged with Leishmania
major extract in vitro). Production of certain cytokines in culture after a short incubation
period is evidence of sensitization. It was anticipated that immune phenotypes and
cytokine profiles of these pups would be modulated.

Significance
This work is relevant to human biology and information derived could impact
current standards of practice. The incidence of pre-term births and low birth weight
babies is rising and has become a “vexing national problem”(Creasy, 1993). These
babies would be less able than adults to recruit the full repertoire of immune responses
needed to defend against most pathogens because inflammatory responses are not
matured. With knowledge of developmental profiles of immune phenotypes and
function, clinicians could more effectively prescribe treatments based on anticipated
immune cell responses. For treatment of neonates in the future, it would be advantageous
to have the ability to selectively advance or forestall development of particular host
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defenses in predictable and quantitative ways. This information could be acquired
through studies of manipulating maternal immune responses and observing their
influences on perinatal development. Conceivably, proactive prenatal treatments may
specifically enhance host defenses or suppress hyperactive responses as in aggressionmediated autoimmunity or allergies. Diagnostic values derived from this study would
help define age-related and environment-dependent norms in development of perinatal
immune responses. The practical value of this information would be for physicians to
optimize an infant vaccination schedule based upon the relative state of immune
responsiveness toward developing tolerance or aggression. Or perhaps down-regulate the
immune system in utero of a fetus destined to receive an organ transplant.

CHAPTER TWO
MATERIALS AND METHODS
Animals
CD-I mice, a genetically wild-type strain, and C57BL/6 mice, an inbred strain,
were purchased from Charles River Laboratories (Wilmington, MA) and Jackson
Laboratories, (Bar Harbor, ME), respectively. Compared to the usual non-inflammatory,
basal immune system of outbred populations, C57BL/6 inbred mice predominantly
express a strong bias to inflammatory (Thl) type immune responses. The Thl bias is
evidenced by rapid rejection of male skin isografts by females (Gasser & Silvers, 1971),
strong reaction to PHA-stimulation (Heilman & Fowler, 1972), and resistance to both
anaphylactic shock (Treadwell, 1969) and Leishmania major infection (Krishnan et al.,
1996a; 1996b). Choice of this mouse strain, with a bias towards Thl immunity, served to
address the hypothesis that accelerated development in a neonate of an adult-like
immunophenotype is prerequisite to expression of aggressive alloreactivity.

Breeding program
The first pregnant CD-I and C57B1/6 mice arrived in the vivarium on gestational
day 13. All mice were housed individually in small cages in the same room and
maintained in a 12- and 12-hour light-dark cycle. Postpartum females, adult males and
progeny provided the breeding nucleus needed to provide additional pups for later
studies. A “trios” method of breeding was employed. Briefly, one male was mated to
two females and housed together for 48 hours. Females were then individually housed; a
29
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vaginal plug confirmed that copulation had occurred. The limited duration of conspecific
exposure coordinated the timing of birth. Body weights of female breeders were
measured daily to confirm the successful progress of pregnancy.

Collection of blood and spleen
Mice 10 days of age or less were killed by decapitation and blood was collected
into heparinized capillary tubes from cut surface of the body. For 20- and 45 days old
groups, blood was collected from individual mice by cardiac puncture following
pentobarbital anesthesia (40 mg/kg body weight); then mice were killed by decapitation.
The spleen was extracted from the peritoneal cavity of each mouse under sterile
procedures, weighed without mesenteric fat, and placed in sterile RPMI 1640 media
(Fisher Scientific, Pittsburgh, PA) at room temperature. Lymphocytes were harvested
within 30 min. Briefly, a spleen cell suspension was prepared by gently pressing tissue
through a fine nylon mesh sieve and resuspending in complete media (RPMI-1640
containing prescreened 10% fetal calf serum and 1% penicillin/streptomycin). These
reagents were purchased from Fisher Scientific, Pittsburgh, PA. Leukocytes in all blood
and spleen cell suspensions were counted with a Unopette hemocytometer (Becton
Dickinson, Franklin Lakes, NJ).
Pools were created by mixing blood or spleens of randomly-sorted pups from
different litters of the same age. The numbers of groups (pools or individuals), and of
pups per pool, used in these experiments are outlined in Table 2.1. Each pool contained 8
pups each for ages 0, 1 and 2 days. Although adequate sample volumes were obtained
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for immunophenotyping, it was impractical to perform cell-sorting experiments for study
of cytokine production in mice before 3 days of age.

Table 2.1. Numbers of infant and young adult mice used to create pools, and
number of pools or individuals, used for immunophenotyping and cell sorting
experiments.
Age
(days)
0 (birth)
1
2
3
4

5
10
20
45

Experiment
Phenotyping
Phenotyping
Phenotyping
Phenotyping & Sorting
Phenotyping & Sorting
Phenotyping & Sorting
Phenotyping & Sorting
Phenotyping & Sorting
Phenotyping & Sorting

Number
(pools or individuals)
6
6
6
6
6
6
6
6
6

Pups/Pool
8
8

8
24

13
10
9
5

1

Immunophenotyping
Lymphocytes in blood or spleen were stained with fluorochrome-labeled
monoclonal antibodies for acquisition and analysis by flow cytometry (Patrick et al.,
1984; Bray & Landay, 1989). Single cell preparations from whole blood and spleen (lx
105 cells/10 pL/tube) were stained with 10 pL fluorochrome-conjugated monoclonal
antibodies (mAb). A monoclonal antibody panel was constructed for two(fluoroisothiocyanate [FITC] and phycoerythrin [PE]) and three-color
immunophenotyping (FITC, PE, and Cy-Chrome). Two-color analysis was used to
enumerate B versus T cells (CD19*FITC/CD3*PE), T helper/inducer cells
(CD4*FITC/CD3*PE), T cytotoxic/suppressor cells (CD8*FITC/CD3*PE) and natural
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killer cells (CD3*FITC/NK1.1*PE). Three-color analysis was used to assess naive and
memory T helper cells (CD62L*FITC/CD44*PE/CD4*Cy-Chrome). All rat anti-mouse
monoclonal antibodies were obtained from PharMingen (San Diego, CA), except
CD3*FITC that was hamster anti-mouse antibody obtained from Caltag Laboratories
(San Francisco, CA). After incubation (15 min, 4°C), erythrocytes were lysed with 0.8%
ammonium chloride solution and samples centrifuged at 300 x g for 5 min. Each
supernatant was aspirated and cell pellets resuspended in 300 pL phosphate buffered
saline (PBS).
Cells (5000) were acquired and analyzed on a Fluorescence-Activated Cell Sorter
with Consort 32 software (FACSort, Becton Dickinson, San Jose, CA). Using side (SSC)
and forward (FSC) light scatter parameters, two morphologically distinct cell populations
were observed in blood and spleen of newborn mice, lymphocytes and granulocytes
(Figure 2.1, top right). Lymphocyte and monocyte populations at these young ages
demonstrated extensive overlap by morphological analysis (Figure 2.1, top panels).
Thus, T (CD3) and B (CD 19) cells were back-gated to allow definition of the lymphocyte
population. In older pups, a sparse population of monocytes became evident by day 5
and morphological resolution improved to the extent that backgating proved unnecessary.
Through this gate, 5000 events were acquired for CD3, CD3CD4, CD3CD8, NK and
CD 19 cells (Figure 2.2).
Analytical controls included (a) unstained cells to assess degree of
autofluorescence, and (b) cells mixed with isotype antibody (R-PE rat IgGl,

k

standard; R-PE hamster IgG isotype standard, group 1

isotype

FITC rat IgG2b,

k

isotype
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standard; FITC rat IgG2a,

k

isotype standard; FITC rat IgM,

k

isotype standard) to

evaluate degree of nonspecific staining. Furthermore, an unlabeled, purified rat anti
mouse CD16/CD32 (FcgIII/II receptor; PharMingen, San Diego, CA) monoclonal
antibody was used as blocking agent to ensure lower levels of non-specific binding that
might occur through Fc receptors expressed by NK cells, monocytes, macrophages,
granulocytes and mast cells.
Three-color analysis was used to quantify naive and memory T helper cell subset
populations co-expressing different degrees of CD4, CD44 and CD62L (Barrat et al.,
1995; Sprent & Tough, 1994; Mocci & Coffman, 1997). Briefly, acquisition and analysis
were performed on cells passed through a fluorescence gate including only CD4 cell
population (FL2/SSC plot) and a morphological gate excluding monocytes and debris
(SSC/FSC plot). Only the events acquired through this dual-gating scheme were
analyzed for expression of CD62L and CD44 on a FL1/FL3 fluorescent dot plot.
Proportions of lymphocyte populations (CD3, CD3CD4, CD3CD8, NK, CD19)
were expressed as percentages normalized to lymphocyte purity (sum of lymphocyte
subsets; CD 19 plus CD4 plus CDS plus NK). Average lymphocyte purity within the
morphological gate (SSC/FSC plot) are listed in Table 2.2. This normalization excluded
debris, other non-lymphoid cells (mainly monocytes), and Ty8 cells (CD3posCD4neg
CD8neg). Consistency of results using this normalization was empirically tested by first
artificially decreasing the lymphocyte purity (by re-analyzing the dot plots) in analyses of
whole blood samples from older mice not requiring this normalization, and then
comparing the results to those originally obtained on the same preparations. This test
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Figure 2.1. Morphological plot following flow cytometry of lysed blood cells from adult
(45 days) and newborn (day of birth) CD-I mice. Top left panel: Three distinct
populations of leukocytes are evident in the 45-day-old mouse, lymphocytes, monocytes
and polymorphonuclear (PMN) cells. The gate (dashed line) encompasses lymphocytes
as well as some debris and non-lymphoid cells. Lymphocytes are enriched within the
gate of mice from 2 days of age and older. Top right panel: Within the gate,
morphological overlap among different leukocyte populations prior to day 2 required
assessment of lymphocyte purity (sum of percentages of CD 19, CD4, CDS and NK cells
relative to gated events based upon bivariate analysis of two-color fluorescent dot plots).
Subsequently, lymphocyte subset percentages were normalized to the lymphocyte purity
for each age. Bottom panels: Assessment of newborn lymphocyte percent (sum of
percentages of CD19, CDS and NK cells) relative to all leukocytes (FSC vs. SSC events
with a gate around the monocytes, lymphocytes and granulocytes and excluding low-end
debris, with a FSC threshold set at channel 200). The percentage of lymphocytes (of the
WBC) and the percentage of each lymphocyte subset were used to generate absolute
numbers of each cell phenotype.

35

£
2-

£
2-

b

CD3e *I 46V.
T CELLS

c

29V.
CD3e+CD4+ T CELLS

'X,-

;V. -39V. B CELLS

r*

i’.a

&
O-.

400

600

800

1000

life-';
0

200

400

1

600

800

1000

s0
;•

d

8*

e

NK CELLS

12V
CD3e+CDS+ T'CELLS
cu
cs>
0

200

1 400

600

800

•.-iW
•- «r

-

'
,46V CDSe-ti; T CELLS

200

400 ' ' 600 ' ' 800

4&r
wM
200

t
600

800 ' '1000

Figure 2.2. Immunophenotypic bivariate (two-color, FITC and PE) analysis of 45-dayold CD-I mouse lymphocytes. This was achieved first by analyzing cells in a gate set on
morphological characteristics, volume (cell size) and internal complexity (e.g.,
granularity) (morphological plot a). Second, cells within this gate were studied for
differential expression of cluster of differentiation (CD) molecules (fluorescent dot
plots b-e). Plot a: Morphological plot of blood leukocytes with gate drawn around
lymphocytes. Through this gate, 5000 cells were acquired and analyzed for expression of
CD. The immuno-phenotyping panel included cells reacted with fluorochromeconjugated monoclonal antibodies in the following combinations: B (CD 19) and T (CDS)
cells (mutually exclusive expression, plot b), T helper/inducer, monocytes, macrophages
(CD4) and T cells (CDS), (co-expression, plot c), T cytotoxic/suppressor, natural killer
cells (CD8) and T cells (CDS) (co-expression, plot d), T cells (CDS) and natural killer
cells (NK-1.1) (mutually exclusive expression, plot e). In these analyses of each
combination, cells not expressing the specific CD molecules are found in the bottom left
quadrant of dot plots (b-e). In mutually exclusive combinations (plots b and e), nonspecifically-stained cells (double-stained) are found in the top right quadrant. In co
expression combinations (plots c and d), non-specifically-stained cells are found in the
bottom right quadrant.
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Table 2.2. Lymphocyte purity (mean) of gated cells measured within the morphological
gate (side scatter versus forward scatter) set during acquisition of mouse cells.

Age (days)
Blood
Spleen

0
61.3

78.5

1
60.1
79.1

Lymphocyte Purity (mean percent)
4
5
10
2
3
90.1
85.1
73.3
85.0
80.7
63.8
76.0
78.3
90.1
84.7

20
83.4
76.1

45
91.7

86.3

revealed a coefficient of assay variation of 1.4% (Figure 2.3). Normalization was not
required for analyzing T helper cells for CD62L and CD44 expression because these cells
were selectively gated, based on their far red (Cy-Chrome) fluorochrome characteristic.
Absolute numbers of each population were generated by multiplying white blood cell
(WBC) counts by the sum of proportions of lymphocyte subsets (i.e., S [CD19 + CD3 +
NK]; Figure 2.1, bottom panels) and again by proportion of each population (CD3,
CD3CD4, CD3CD8, NK, and CD 19 subsets). Absolute numbers of T helper cells
analyzed for expression of CD62L and CD44 were similarly generated. Cell numbers in
spleens were expressed as cells per whole organ (not per gram tissue weight) so as to
illustrate the significant increase in total cells accumulating in this secondary lymphoid
organ. (Figure 2.4).
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Figure 2.3. Correlation between two flow cytometric gating analyses (different
lymphocyte purities, LP, resulting from gating cells of very young versus older mice;
Low LP is defined as a wide gate around lymphocytes and High LP, a tight gate). When
analyzing these cells, proportions of lymphocyte subpopulations (CD3, CD3CD4,
CD3CD8, NK, CD 19) were expressed as percentages normalized to LP (CD19+CD4
+CD8+NK = total lymphocytes) within the analysis gate. This normalization allowed for
exclusion of debris, non-lymphoid cells (mainly monocytes), and y6 T cells
Since monocytes and
(CD3posCD4negCD8neg) found within the analysis gate,
granulocytes of infant mice have a higher degree of morphological overlap with the
lymphocyte population than those of older mice, a test of the appropriateness of this
normalization scheme was necessary. Consistency of results using this normalization
was empirically tested by decreasing the lymphocyte purity (opening the analysis gate) in
whole blood analysis of samples having high LP (mean = 89% lymphocyte purity). The
LP was reduced in these samples by 16% on average. Percentages of lymphocyte
subpopulations (CD3, CD3CD4, CD3CD8, NK, CD 19) were then generated through
these two gates and correlated. This test revealed a correlation coefficient (R2) of 0.98.
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CD4 cell isolation (“sorted CD4 ”) for cytokine assessment
CD4 splenocytes were positively sorted with “DYNABEADS™ Mouse CD4”
(Dynal, Lake Success, NY), immunomagnetic beads conjugated with rat anti-mouse CD4
(L3T4) monoclonal antibody. Mixtures of cells and dynabeads were rocked 45 min at
4°C to bind the antibody-bead complex to cells. Subsequently, CD4 cells were captured
with a magnet pressed against the test tube; non-CD4 cells were collected as free cells in
suspension in aspirated supernatant. Free non-CD4 cells served as antigen presenting
cells (see below). CD4 cells were obtained when disassociated from cell-immunobead
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Figure 2.4 White Blood Cell (WBC) counts of single cell suspensions
prepared from spleens of CD1 mice. Data points are the mean of 5
samples. Samples represent pools of randomized pups (day 3, 24/pool; day
4, 13/pool; day 5, 10/pool; day 10, 9/pool, day 20, 5/pool), or individual
mice (day 45). Note scale difference for cell numbers per gram tissue
compared to that of the whole spleen.
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conjugates (DETACHaBEAD Mouse CD4, Dynal, Lake Success, NY). Briefly, isolated
CD4 cells (1x10^ cells/100(aL) were incubated with 20uL DETACHaBEAD reagent for
45-60 min at room temperature. After beads were released from cells and collected by
magnet, detached CD4 cells were collected in supernatant, washed twice with RPMI
1640, and resuspended in complete media.

Accessory cell isolation (“sorted APC”) for cytokine assessment
Antigen presenting cells (APC) were purified (enriched) by negative-sorting
(treating aspirated supernatant with DYNABEADS conjugated to Thy-1.2 mAb; Dynal,
Lake Success, NY). This treatment depleted remaining CDS cells and any CD4 cells not
previously captured. This procedure yielded >95% Thy 1.2-negative cells. Thyl.2negative cells (APC) were washed in RPMI 1640 and resuspended in complete media.

Quantification ofpercent CD4 cells, and purity of sorted CD4 and APC
Two-color immunofluorescence was used to quantify percent splenic CD4 cells,
and purity of CD4 and APC cell isolation experiments (Figure 2.5). Lymphocyte
suspensions were stained (hamster anti-mouse CD3*FITC, Caltag Laboratories, San
Francisco, CA; and rat anti mouse CD4* or CD8*PE, PharMingen, San Diego, CA) and
analyzed as previously described.
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Figure 2.5
cell suspensions of CD-I mouse spleens. Top panels illustrate the morphological dot
plots of sorted CD4 and APC. Note homogeneous characteristics of CD4 cells (top left)
in contrast to heterogeneous nature of APC populations (top right). The APC population
contains at least two subsets of cells with antigen presenting capabilities, B cells and
monocytes. To confirm sorting efficiency, purity of sorted cells was evaluated by twocolor immunofluorescence (CD4CD3, bottom left or CD8CD3, bottom right).
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T cell stimulation assay
Splenocytes were collected from spleens as described above. Subsequently, cell
cultures were set up in 24-well plates (Fisher Scientific, Pittsburgh, PA). Cultures
consisted of either unsorted single cell spleen suspensions (SSCS), or mixtures of sorted
CD4 splenocytes (1x10^ cells in ImL) and sorted APC (2x10^ cells in ImL). To obtain
a constant number of CD4 cells in each culture, absolute numbers of CD4 cells in
unsorted cell preparations were determined by flow cytometry. An aliquot containing
1x10° CD4-positive splenocytes was added to each well with ImL optimally diluted CDS
monoclonal antibody (clone 145-2C11, PharMingen, San Diego, CA). Each culture
volume was brought up to 2 mL with complete media.

Production of CD3 monoclonal antibody for T cell stimulation experiments
Cell clone 145-201 (PharMingen, San Diego, CA) producing anti-CD3
monoclonal antibody was grown in T-150 flasks with complete media. Cells were
allowed to grow to culture media exhaustion, when most cells were dead. The
conditioned media was collected and centrifuged at 400 g for 30 min at 4°C to eliminate
cells and cellular debris. This conditioned media was used as the source of CDS antibody
for cell culture stimulation experiments.

Stimulation of T cells: optimal CDS monoclonal antibody titer
Serial dilution of CD3 monoclonal antibody required for optimal stimulation of T
cells was determined by quantifying 3H-thymidine incorporation by blast cells. An 8-fold
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dilution produced greatest proliferation (Figure 2.6). This dilution was chosen as optimal
concentration for all subsequent experiments. Cell cultures were set up and incubated at
37°C in 5% CO2 in 100% humidified air. CDS antibody was not added to control cell
cultures. After 24 hr, supernatants were collected and stored frozen (-70°C) until
assessed for cytokines.
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Figure 2.6. Titration of hamster anti-mouse CDS monoclonal antibody. Clone 145-2C11
(American Type Culture Collection, Rockville, Maryland) was grown in Dulbecco
Modified Eagles Medium supplemented with 10% fetal calf serum, 1% penicillin/
streptomycin and 1% L-Glutamine (Fisher Scientific, Houston, TX). Cell cultures were
incubated at 37°C in 5% CO2 in humidified air and allowed to grow until media
exhaustion. Culture supernatant was filtered (0.2 micron membrane; Fisher Scientific,
Houston, TX) and titered for optimal antibody concentration using a suspension of CD-I
mouse spleen cells (SxlO6 cells/well). Cells were incubated 24 or 42 hours, and pulsed
18 hr prior to end of incubation with 1 mCi (methyl)-3H (New England Nuclear, Boston,
MA) in RPMI 1640 (Fisher Scientific, Houston, TX). Cells were harvested (Skatron
filter mats, Skatron, Sterling, VA), and radionucleotide incorporation assessed by liquid
scintillation counting (Beckman Ready Safe scintillation cocktail, Beckman Instruments
Inc, Fullerton, CA; Packard Cobra auto-gamma counter, Packard Instruments Co.,
Downers Grove, IE).
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Cytokine assays
Commercial cytokine ELISA kits from ENDOGEN (Woburn, MA) were used to
assess IL-2, IL-4 and IFNy production by murine splenocytes after CD3 ligation. Assay
procedures followed manufacture’s instructions.

Briefly, standard sandwich ELISA

technique utilizing capture antibody (96-well microculture plates; Fisher Scientific,
Pittsburgh, PA) and enzyme-conjugated detection antibody was employed. Plates were
read in a Mark II Plate Reader (Dynex Technologies Inc, Chantilly, VA) at appropriate
wavelengths indicated in each cytokine kit. Throughout this study, two (one high, one
low) control samples of known concentrations of specific cytokine were included in each
assay to assure reproducibility. Standards and samples were assayed in duplicate.
Optimization ofLeishmania major antigen for in vivo and in vitro use
Leishmania major (L. major) extract of killed protozoa (sonicated) (Antibody
Systems, Hurst, TX) was suspended in saline (1 mg/mL). A pilot study was conducted
with pregnant and non-pregnant (n=6) mice to determine optimal in vivo dose to induce a
Thl response (IL-2 and IFNy production) Table 2.3. Each animal received 175 pL
(intraperitoneal injection) of either T. major extract (pregnant, n=3; control, n=3) or
saline (pregnant, n=3; control, n=3). This dose was recommended by Antibody Systems
for Thl induction. Pregnant animals were inoculated once (gestational day 8, 11 or 13);
no further injections were given as a precaution to avoid induction of premature labor and
delivery. Spleens and sera were collected from dams on day of parturition (gestational
day 20) and from non-pregnant controls 9 days post-inoculation.
Successful immunization of these animals was confirmed by assessing cytokine
concentrations (IL-2, IFNy, IL-4) in serum and in supernatants from spleen cells in
culture after in vitro challenge with L. major (recall). Sera for these determinations were
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obtained by cardiac exsanguination under sodium pentobarbital anesthesia as previously
described. For the recall study, spleens were harvested from exsanguinated mice and
single cell suspensions prepared as described. Cells were incubated (IxlO6 cells/well) in
96-well microculture plates (Fisher Scientific, Pittsburgh, PA) with 16.6 pg/well ofZ.
major extract (“starting” concentration suggested by supplier) in complete media for 72
hours in 5% CO2 in humidified air at 37°C. At end of incubation, cell culture
supernatants were collected and assayed for IL-2, IFNy and IL-4.

Statistical analysis
One-way ANOVA and Duncan’s post hoc test for multiple comparisons among
different ages were calculated. If test for homosedasticity was significant (greater than
the critical value for F-max test for homogeneity of variances), data were log
transformed. After transformation, if significant homogeneity of variances persisted, a
Kruskal Wallis ANOVA with multiple comparisons was performed to assess differences
among age groups. Two-way ANOVA was used to determine treatment effects of T.
major extract inoculations. Furthermore, t tests were used as post hoc tests to determine
group differences. P<0.05 was considered significant.

CHAPTER THREE
ONTOGENY OF IMMUNOPHENOTYPES

This chapter presents the results from experiments concerning specific aims 1 and
2. The objective of Specific Aim #1 was to determine profiles of cell phenotypes in
blood and spleen of individuals possessing normal, non-aggressive (defaults to Th2)
immune characteristics (/.£., an outbred specie) during the postnatal period. Absolute
numbers and proportions were determined to provide a complete picture of
lymphocyte population dynamics during this period of immune maturation. In
Specific Aim #2, the objective was to test the hypothesis that the profile of immune
cell phenotype development was accelerated in Thl-prone mice.
The percentage of lymphocytes, relative to leukocytes, increase from day 5 to day
56. King et al. (1991) reported the profile of Thyl.2 (pan T), CD4, CD5, CDS, and B
cells between 5 and 56 days, but failed to define the earliest events involved in
establishing the immune system. In the present study, the developmental profile was
characterized each day starting at birth through d5, and then at intervals. The period
spanning the first few postnatal days are critical since thymic exportation has been
reported to have begun by d3 (Kelly & Scollay, 1992). Furthermore, King et al (1991)
reported incomplete data: percentages (no absolute numbers were included) of all
leukocytes (not lymphocytes) in the spleen (no blood cells) derived from univariate
analyses (single “markers” or antigens) of cells. Multivariate analysis of immune cell
phenotypes is prerequisite to accurately assess this aspect of immune status because some
45
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antigens are expressed by more than one cell type (see Immunophenotyping in Materials
and Methods, Chapter 2). Bivariate analysis can be used, then, to delineate critical
fluctuations in lymphocyte subtype populations over time.
In this study, percentage and absolute numbers of lymphocytes were enumerated
for several immunophenotypes using two-color (FITC/PE) multivariate analysis of
CD19/CD3 (T versus B), CD4/CD3 (T helper/inducer, Th), CD8/CD3 (T
cytotoxic/suppressor, Tc/s) and CD3/NK1.1 (T versus NK) cells. Three-color
(FITC/PE/Cy-Chrome) multivariate analysis was required to define naive and memory
subsets of T helper cells. This study provides critical data not reported previously,
defining the ontogeny of naive and memory T helper cells (defined by co-expression of
CD62L/CD44/CD4); such definition is essential to understanding development of adult
immunity. King et al. (1991) only reported proportions of leukocytes in spleens of
female A/J inbred mice 5-56 days old, while Kelly & Scollay (1992) enumerated absolute
numbers of cells in lymph nodes of CBA/CaH mice 1-7 and 38 days old. Furthermore,
the literature reveals only few studies of functional abilities with respect to development
of adult-like quality and quantity of responsiveness. For example, once a week for ten
weeks, Fomi et al. (1988) assessed splenic B and T cell activation in germ-free BALB/c
mice, starting at 7 days of age. Piguet et al. (1981) compared responsiveness of lymph
node cells of 5-day-old pups to those of adult CBA and BALB/c mice. There are no
studies describing the earliest appearance of specific immune cell populations that are
destined to populate secondary lymphoid tissues and establish a mature immune system.
The current study focused on defining the sequence and tempo of these critical steps.
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Of particular importance to establishing development of mature
immunocompetence is the delineation of timing and proportions of T cell subset
trafficking to the periphery, as these cells are required for establishing Thl/Th2 immune
balance. It has been established that thymic-educated T cells exit the thymus as naive
immune cells that are the nucleus of the adult cell-mediated immune system, but the
order of appearance and the age at which naive T cells acquire adult immune attributes
(e.g., memory) in peripheral tissues are not known. This study is unique in that it
configured the timetable and sequence of immune cell development by identifying and
quantifying, from birth to adulthood, the immune cell populations as they emigrated into
circulation and then spleen. This was accomplished through immunophenotyping
(fluorochrome-conjugated monoclonal antibodies and fluorescence-activated flow
cytometric analysis) and multivariate analyses of blood and spleen lymphocyte
populations (described in Chapter 2).

Postnatal development of leukocytes and lymphocytes in blood and spleen of CD-I mice
There were two remarkable features in the developmental profile of total
leukocytes, a dramatic peak in cell number in blood occurs on dlO and there is a gradual
increase in cell numbers in spleen from birth to adulthood. In blood, white blood cells
increased to maximum levels at 10 days of age (Figure 3.1, top panel; ANOVA, p<0.05),
then declined to a nadir by d45 (significantly lower than dO). Lymphocyte populations
paralleled the leukocyte profile. Lymphocytes gradually increased to peak on dlO and
declined to a plateau by d20, persisting into adulthood. Such changes in lymphocyte
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Figure 3.1. Number of leukocytes (solid circles) and lymphocytes (open triangles) in
blood (top) and spleen (bottom) of CD-I mice (male and female) at various ages during
postnatal development. Data points are mean±SE of 6 samples. Samples represent pools
of pups (days 0-2, 8/pool; d3, 24/pool; d4, 13/pool; d5, 10/pool; dlO, 9/pool, d20, 5/pool),
or individual mice (d45), as outlined in Chapter 2. Note scale difference for cell numbers
of blood (per mL) compared to that of spleen (per spleen). Statistical differences
(p<0.05) among age groups are indicated by “a” versus dO, “b” versus days 0-3, “c”
versus dlO, “d” versus d20. Numbers of lymphocytes in blood on dlO is different from
all previous age groups. For this data set (df=8), the one-way ANOVA with Duncan’s
multiple range test generated an F statistic >3.72, while the Kruskal-Wallis test with Chi
Square analysis was >74. See statistical analysis section in Materials and Methods (Ch.
2) for further details. Inset graphs are body and spleen weights at each postnatal age. At
some ages, symbols obscure SE bars.
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cell numbers in circulation are likely to reflect migration of cells from primary to
secondary lymphoid organs (Scollay & Shortman, 1984.). The low numbers of blood
leukocytes and lymphocytes beyond dlO do not reflect the exponential increase in body
weight (Figure 3.1, Top panel inset). The significant gain in spleen leukocytes and
lymphocytes beyond d20 were not associated with a gain in spleen weight (Figure 3.1,
bottom panel inset).
Splenic leukocytes increased exponentially starting at postnatal d5 (Figure 3.1,
bottom panel; ANOVA, p<0.05). Adult numbers were attained by d20, and continued to
increase. In contrast to blood, age-related gains in spleen weight were correlated with
increased spleen weight (Figure 3.1, bottom panel inset), and were reflected in the
leukocyte and lymphocyte profiles. Thus, spleen size was directly related to number of
resident lymphocytes, whether of immigrant origin or in situ proliferation.
Increases in blood lymphocyte numbers preceded those in spleen (viz., days 0-3,
-10%; days 4-20, -35%; and d45, -70% in blood versus days 0-5, -35%, days 10-20,
-60% and d45, -82% in spleen). This pattern of seeding blood before spleen and lymph
nodes (“shadow” or “echo”) is classically interpreted as trafficking of lymphocytes from
primary organs (bone marrow and thymus) through blood to secondary organs with
perhaps a relatively small contribution to the splenic population coming from in situ
clonal expansion. (Scollay & Shortman, 1984). Which cell types contribute to this
massive increase in spleen size? Are large numbers of nai've cells immigrating into
secondary lymphoid compartments, or are only small numbers of naive cells
immigrating, maturing and undergoing clonal expansion? To answer these questions,
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subset immunophenotyping analyses were performed on blood and spleen immune cells
across this period of development.

Postnatal development of lymphocyte subsets in blood and spleen of CD-I mice
Profiles of immune cell phenotypes within an organ, e.g., blood or spleen, provide
a general indication of immune system maturation. However, a census of cell types
available is prerequisite for determining functional capabilities. Thus, the specific aim of
this experiment was to define the lymphocyte subsets in circulation, and in spleen, at
frequent intervals throughout postnatal development. Fluorochrome-conjugated
monoclonal antibodies directed to specific cell membrane antigens were used to identify
B cells (CD20), natural killer cells (NK1.1), T cells (CD3), T helper cells (CD3CD4), and
T cytotoxic cells (CD3CD8) in blood and spleen. Volume, internal complexity and
emitted-light characteristics of each cell type were acquired and analyzed using flow
cytometer technology (see Chapter 2).

Postnatal development ofB lymphocytes (CD 19) in blood and spleen of CD-I mice
A large proportion of B cells (CD 19) was present at birth (blood, 90%, spleen =
97%: ANOVA, p<0.05; Figure 3.2, left panels). B cell proportions rapidly declined
(blood, 35%; spleen, 78%) by dlO. Proportions of circulating B cells demonstrated a
secondary rise by d20 that was sustained through d45. In spleen, B cells declined in
proportion to other cells for the first 10 days, increased by d20, then decreased to adult
proportions by d45.
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As proportions of B cells declined with age , B cell numbers rapidly increased
during the first 10 days in blood and up to day 20 of age in spleen (ANOVA, p<0.05;
Figure 3.2, right panels). The exponential increase in splenic B cells over the first 20
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Figure 3.2. Percentage (left panels) and number (right panels) of B cells (CD 19) in
blood (top panels) and spleen (bottom panels) of CD-I mice (male and female) at various
ages during postnatal development.
Data points are mean±SE of 6 samples.
Construction of pools is described in Figure 3.1. Statistical differences (p <0.05) among
age groups are indicated by “a” versus dO and 1, “b” versus days 0-4, 20 and 45 days of
age (except percent in blood on d45), “c” is compared to all previous age groups (except
absolute numbers in spleen on d20). For this data set (df=8), one-way ANOVA with
Duncan’s multiple range test generated an F statistic >28.7, while Kruskal-Wallis test
with Chi Square analysis was >27. At some ages, symbols obscure SE bars.
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days (90-fold since birth) appears to directly result from trafficking and seeding B cells
from blood. B cell numbers reached adult levels in both blood and spleen by 20 days. B
cell concentrations in the spleen by postnatal d20 are some 165 times greater than that in
blood.

Postnatal development ofNK cells (NK1.1) in blood and spleen of CD-I mice
Natural killer cells represent about 5% of all lymphocytes in these two
compartments (Figure 3.3, left panels, ANOVA, p<0.05). This proportion varies over a
narrow range (1-5%) in blood and spleen during postnatal development. The profile of
absolute numbers in circulation (Figure 3.3, top right panel) was similar to their
proportions in blood (Figure 3.3, top left panel). In the spleen, NK cell numbers increase
exponentially after postnatal dlO (ANOVA, p<0.05). Ultimately, the magnitude of NK
cell numbers is some 30-fold greater in spleen than blood by day 45 of age.

Postnatal development ofT lymphocytes (CDS) in blood and spleen of CD-I mice
The last major class of lymphocytes, T cells (CD3), encompass two main subtypes,
Th (CD3CD4) and Tc/s (CD3CD8) cells, and together represent the vast majority of
circulating immune cells. (There is a minor subpopulation of T cells that express a
different phenotype, y8 rather than a(3 receptors, and no CD4 or CDS. These cells are
rarely found in circulation as they home into epithelial tissues, where they prevail, early in
development; Haas et al, 1993). All T cells rapidly reach peak proportions in blood by
dlO (Figure 3.4, top left panel). The initial rise in T cells occurs by d3 {versus birth,
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ANOVA, p<0.05) and is predominantly due to expansion of T helper cells. In the spleen,
the peak also occurs for all T cells on dlO. Interestingly, Tc/s cells appear in blood and
spleen some 24-48 hours ahead of Th cells. Advanced exportation of suppressor cells
relative to other T effector cells is also observed during immune cell re-population
(ontology recapitulated) after total body lethal irradiation and may protect against
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Figure 3.3. Percent (left panels) and numbers (right panels) of natural killer cells relative
to total lymphocytes in blood (top panels) and spleen (bottom panels) of CD-I mice
(male and female) at various ages during postnatal development. Data are mean±SE of 6
samples. Construction of pools is described in Figure 3.1. Statistical differences (p
<0.05) among age groups are indicated by “a” versus dO, “b” versus d2, “c” versus d5,
“d” versus dlO, and “e” versus d20. For this data set (df=8), one-way ANOVA with
Duncan’s multiple range test generated an F statistic 6.8, while Kruskal-Wallis test with
Chi Square analysis was >26.6. At some ages, symbols obscure SE bars.
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uncontrolled cell-mediated toxicity (Strober, 1984). This peak is a 50-fold expansion of
circulating T cells, and T cell subsets from birth occurs by dlO (ANOVA, p<0.05; Figure
3.4, right top panel). From this peak, T cell numbers decline to adult levels by d20.
Congruence of developmental profiles for T cell percentages and numbers in blood reflects
the transport function of the circulatory system for cell trafficking between various
lymphoid compartments.
Within the spleen, exponential increases in absolute numbers of all T cells
continue throughout postnatal development (Figure 3.4; bottom right panel). By the first
postnatal day, T cell numbers are already increased significantly compared to dO
(ANOVA, p<0.05). These cells increase exponentially with age with the greatest rise
occurring in T helper cell numbers. Of interest is, after d2, the total number CD3+ T
cells exceeds the sum of T helper and T cytotoxic cells in either compartment, suggesting
the presence of y5 T cells (Bluestone et al, 1991; Witherden et al., 1994; Tough &
Sprent, 1998).
To appropriately compare the changes of cell numbers in blood and spleen, the
total number of T cells per total blood volume was calculated (Figure 3.5). Total blood
volumes were calculated as 70 mL/kg of body weight. The profiles obtained were similar
to those obtained when the data is presented on a per milliliter basis (Figure 3.4, top right
panel). A neonatal peak at day 10 is observed in blood, signifying the T cell exodus from
thymus. By d45, the cell numbers in blood increase to a level higher than the neonatal
peak on dlO. The latter observation is different than that seen if T cell numbers are
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plotted on a per mL basis, when numbers are equivalent to those found on d20, a level
below the day 10 peak.

Differentiation ofT helper cells (naive versus memory) during development in CD-I mice
Acquisition of memory by T helper cells is an indicator of immune maturation (Swain &
Bradley, 1992). Development of this differentiating process was studied by assessing
specific cell markers associated with expression of naive (CD62L^0SCD44^0W) and
memory (CD62Lne^CD44^^) capabilities. Proportions of naive and memory T helper
cells were inversely correlated during the first 20 days in blood (Figure 3.5, top left
panel) and spleen (Figure 3.5, bottom left panel) (ANOVA, p<0.05). After a rapid rise in
blood-borne naive cells during the first 10 days, levels are maintained into adulthood.
The proportion in spleen peaks on dlO and then declines significantly by d45 (ANOVA,
p<0.05).
As expected, memory cells decline in inverse proportion to the naive T cells.
Memory T cells constitute less than 3% of T helper lymphocytes in circulation by
adulthood. Seeding of splenic tissue follows a pattern similar to that in blood but, in this
compartment, memory cells represent a greater portion of the T helper cell population
(Figure 3.5, bottom left panel). By d20, a repertoire of memory T helper cells is well
established.
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Figure 3.4. Percent (left panels) and numbers (right panels) of lymphocytes (T, CD3;
Th, CD3CD4; Tc/s, CD3CD8) in blood (top panels) and spleen (bottom panels) of CD-I
mice (male and female) at various ages during postnatal development. Data points are
the mean±SE of 6 samples. Construction of pools is described in Figure 3.1. Statistical
differences (p <0.05) among age groups are indicated by “a” versus dO, “b” versus 0-3
days of age, “c” versus dlO, “d” versus d20 and “e” versus all previous ages (except
absolute number of CD3 in blood on d20 versus d3). CD4 and CDS values on days 1-5
are significantly different from previous age groups. For this data set (df=8), one-way
ANOVA with Duncan’s multiple range test generated an F statistic >27.4, while KruskalWallis test with Chi Square analysis was >40.1. At some ages, symbols obscure SE bars.
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Figure 3.5. Number of T cells (CD3) in blood of CD-I mice (male and female) at
various ages during postnatal development. Data are expressed as number of T cells per
total volume of blood. Data points are mean±SE of 6 samples. Construction of pools is
described in Figure 3.1. No statistics were generated; this plot is used to illustrate
changes occurring in total cell numbers in circulation. This figure should be compared to
data expressed in figures plotting circulating cell numbers.
Attainment of sufficient numbers of naive and memory T helper cells is a critical
milestone of immune function maturation. It is observed that developmental profiles of
both cell types are similar (Figure 3.6, right panels). In blood, naive T helper cell
numbers rise significantly to peak by dlO, then decline as the animal reaches adulthood.
Although significant, the rise in circulating memory cells is less remarkable, achieving
plateau by d20. Still, numbers of naive and memory T helper cells are relatively low in
circulation compared to those in spleen (Figure 3.6, bottom right panel). Of great
importance to establishing the immune repertoire is the exponential increase in number of

58

NUM

PERCENT

BER

(x 1 0

5

)

80
0.3

3
60

0.2

40
^ 20
*
0

4

2

cT

c/) 0-1

1

0

(D

0

O

0

>,0.0

o

o

o

0
>
03 60

0
>

E

0
^

z

V)

120 "m
40

12
80

40
20

40

8
20

0

0
4

0
0

10

20

30

0

40

10

20

30

40

Age (days)
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T helper cells in blood (top panels) and spleen (bottom panels) in CD-I mice (male and
female) during postnatal development. Data points are mean±SE of 6 samples.
Construction of pools is described in Figure 3.1; note dO-2 were not evaluated. Details of
flow cytometric acquisition and analysis are described in Materials and Methods (Ch. 2).
Statistical differences (p<0.05, df=5) among age groups are indicated by “a” versus d3,
“b” versus 10. “c” indicates p<0.05 compared to all previous age groups. For this data
set (df=8), the one-way ANOVA with Duncan’s multiple range test generated an F
statistic >4.6, Kruskal-Wallis test with Chi Square analysis was >23.3. At some ages,
symbols obscure SE bars.
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naive and memory T helper cells with age (ANOVA, p<0.05). In this respect, the spleen
appears to be an important residence for both subsets of T helper cells.

Immunophenotype maturation in Thl- versus Th2-prone individuals
Observed differences in neonatal immunity raised questions about the
mechanisms underlying apparent variations in Thl immune capabilities. Locksley et al.
(1998) reported that, in mice, Thl and Th2 effector development is influenced by the
genetic make-up. Although specific immune reactivity may be linked to epigenetic
influences (Doria et al, 1997; Conboy et al., 1997, Wills-Karp & Ewart, 1997),
variations in developmental profiles of immune cell phenotypes arising from genetic
influences have not been addressed. Heightened inflammatory responses documented in
the C57B1/6 mouse strain (Krishnan et al, 1996a; 1996b; Treadwell, 1969; Gasser &
Silvers, 1971; Heilman & Fowler, 1972) suggested a bias towards advanced immune cell
development. In contrast to this inbred bias, wild type mice (e.g., CD-I) provide a model
of a more balanced (Th2-prone) immune system. Thus, the specific aim of this
experiment was to determine the developmental profile of the C57B1/6 (Thl-prone)
inbred mouse. Immunophenotypic analyses of blood and spleen populations were
performed as done in CD-I mice.
The general profile of proportions of immune cell phenotypes in blood of
C57BL/6 mice was similar to those in outbred CD-I mice (Table 3.1). Proportionately,
the first significant rise from dO in lymphocyte subsets appears at 3-5 days of age (one
way ANOVA, p<0.05). The nadir on d5 was significantly lower than proportions on all
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other days (one-way ANOVA, p<0.05). The postnatal peaks on d5 for T and T cell
subsets (Th, Tc/s) were significantly higher than all other days. Proportions of NK cells
did not show age-related changes in C57BL/6 mice. In contrast, numbers of all cells in
blood increased exponentially from newborn values to a plateau on d20 that persisted to
day d45.
The first significant rise in proportions of lymphocyte subsets in the spleen
(Table 3.1) appeared on dlO (Th) and d20 (all T and Tc/s) (one-way ANOVA, p<0.05).
T and T cell subsets presented significant age-related changes during postnatal
development, e.g., Th proportions at 10, 20 and 45 days were higher than all previous
ages (one-way ANOVA, p<0.05). Overall, the proportions of T and Th cells increased
linearly with age. Tc/s proportions, on the other hand, reached adult levels by d20.
Proportions of B cells in the spleen did not change.
Spleen cell numbers increased exponentially with age. The first increase (11fold) in WBC from newborn values was observed on dlO (one-way ANOVA, p<0.05).
In contrast, all lymphocytes significantly increased 2.6-fold on d3 over newborn values as
a result, for the most part, to a rise in Th cells; Tc/s and NK cells first increased on dlO
(one-way ANOVA, p<0.05). WBC and all lymphocytes increased 25-fold and 118-fold,
respectively, in spleen by d45. The rise in lymphocytes was due to increases in B (85fold) and T cells (220-fold) since birth. The predominant contributor to the 220-fold rise
in T cells was the increase in Th (527-fold), twice that in Tc/s cells. Thus, accumulation
of cells in spleen over the first 45 days is likely the result of thymic emigrants or in situ
proliferation.
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Comparison of immunophenotype profiles of Thl- and Th2-prone models reveals
an accelerated immune cell development in Thl mice (Table 1). The B cell nadir and T
cell peak proportions in C57BL/6 mice appeared earlier (d5) than in CD-I mice (<dlO;
Figure 3.7). In contrast, leukocytes and lymphocytes in blood peak on d20 in C57BL/6
mice compared to day 10 in CD-I (Figure 3.1, top panel). In support of the Thl bias in
these mice, it was observed that newborn spleens contained 3.7-fold greater numbers of
Th cells than the similarly aged CD-I cohorts. Although this difference was lost by dlO
when CD-I mice had gained twice as many Th cells, a greater Th cell number at an
earlier age is consistent with an advanced immune repertoire expected in Thl-prone
animals. Early accumulation of Th cells may confer an immune advantage to the
C57BL/6 mouse by building a memory repertoire to pathogens at a young age, but also
may give rise to less-controlled cytokine responses, characteristic of this hyper-reactive
mouse strain, because of insufficient regulation by T suppressors.
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Table 3.1. Age-related changes in B (CD19), NK (NK1.1), T (CD3), Th (CD3CD4), and
Tc/s (CD3CD8) cells in blood and spleen of C57B1/6 mice. Data are expressed as mean
percent (±SE) of cells in blood and spleen. P<0.05 indicated by letter versus dO (a), d2
(b), d3 (c), d5 (d), dlO (e), or d20 (f). Note the nadir in blood B cells and peaks in blood T
cells on d5, in advance of those in CD-I mice (shaded).
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Figure 3.7. Percent CD 19 (top panel) and CD4 (bottom panel) in blood of C57BL/6 and
CD-I (male and female) mice during postnatal development. Data points are mean±SE
of 6 samples. Construction of pools is described in Figure 3.1. Details of flow
cytometric acquisition and analysis are described in Materials and Methods (Ch. 2).
Arrows indicate advancements in acquisition of C57BL/6 immunophenotypes compared
to outbred CD-I. On day 5, proportions of CD4 cells are significantly greater in
C57BL/6 (t-test, p<0.05) than CD-I. In contrast, the proportion of B cells is significantly
lower than CD-I (t-test, p<0.05).

CHAPTER FOUR

ONTOGENY OF CYTOKINE RESPONSES

In the previous experiments, critical cell types were identified and enumerated
between birth and maturity. While installation of B, NK and T subsets is requisite for
immune maturation, population of lymphoid compartments is only part of the formula for
survival. Mature functional capabilities are also required, and particularly critical is the
production of cytokines, i.e., soluble proteins or glycoproteins that act as chemical
communicators between cells (Bazan, 1990; Boulay & Paul, 1992). Cytokines bind to
specific receptors on the surface of target cells that are coupled to intracellular signal
transduction and second messenger pathways. Most cytokines are growth and/or
differentiation factors and do not exclusively act on cells within the hematopoietic
system.
Mosmann and colleagues (1986) have defined two categories of cytokines
produced by Th cells, those that promote cell-mediated or inflammatory immunity (Thl)
and those with a bias toward antibody-mediated humoral immunity (Th2). These distinct
functional pathways are antagonistic and, therefore, act to regulate immune responses
(Oppenheim, 1990). For the present investigation, accurate and sensitive assays for Thl
and Th2 cytokine production by spleen cells from CD-I mice were used to determine
maturation of immunocompetence.
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Cytokine production by neonatal inbred mice
Th2 cytokine production predominates in the neonatal period, while adult-like
Thl production is achieved by postnatal day 45. Adkins et al, (1993) have reported that
the immune status of 4-day-old neonatal B ALB/c inbred mice is Th2 dominant.
Activation of lymph node T cells from infant mice by CD3 ligation in the presence of
adult syngeneic antigen presenting cells produces abundant IL-4 (Th2 cytokine) but little
IL-2 (a Thl cytokine). Thl production was established by 5-6 weeks of age but high IL4 production during development was thought to contribute to the inability of young
helper cells to produce Thl cytokines, IL-2 and IFNy.
In defining the functional profile of neonatal cells, these investigators co-cultured
syngeneic adult antigen presenting cells (APC) with isolated CD4+ cells (<2:1 ratio).
This experimental paradigm was expected to clarify mechanisms underlying observed
immaturity of neonatal cells. In their experiments, these investigators employed adult
rather than contemporary APC as costimulators, a decision based on reports of neonatal
APC immaturity. Although some investigators contend that neonatal APC function is
immature (Hunt et al., 1994), others report a 100-fold increase in efficiency over those of
adults (van Tol et al, 1983; 1984a; 1984b; Marwitz et al, 1988). Since lymphocytes and
APC have evolved to function cooperatively, it is logical that function of one cell type at
a specific age would be coordinated with that of the other cell type at that age. With this
rationale, neonatal lymphocytes were expected to function optimally, relative to the
demands at hand, when cooperating with APC of the same stage of development.
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Therefore, in the following experiments, and unique to this work, functional maturation
of neonatal helper lymphocytes was evaluated in context of contemporary rather than
adult costimulators. Also novel in these culture experiments was the preservation of agespecific ratios of Th-to-APC by culturing uncorrupted mixed-cell preparations. This
decision was a logical extension of the immunophenotyping data (Chapter 3) illuminating
dynamic changes occurring in neonatal spleen cell populations. For example, T and B
cell numbers increase disproportionately in the first 10 days, 417- and 18-fold,
respectively. Without consideration of cell proportions, erroneous assessment of
functional capabilities by sorted, isolated subpopulations in cultures is probable.
Although, an alternative approach would have been to assay for optimal responses from
various ratios of Th-to-APC in culture, optimal in vitro responses do not necessarily
reproduce in vivo conditions that reflect age-appropriate cell ratios and cooperative
function.

Developmental profile of cytokine production by single cell suspensions of spleen cells
(allogeneic mixed lymphocyte cultures)
Humoral immunity, acquired passively from maternal immunity, must be
supplemented with cell-mediated immune responses for combating certain pathogens.
Thus, it was hypothesized that T cells of neonatal mice would acquire the capacity to
produce required inflammatory cytokines for mature cellular immune reactions shortly
after birth. These experiments, aimed at testing functional maturation of neonatal T cells,
were designed to take advantage of the innate capacity of T lymphocytes to recognize

67
foreign major histocompatibility antigens (genetic disparity), a classic model of cellmediated, inflammatory reactivity. Capitalizing on genetic disparity of an outbred
population to provide substantial T cell stimulation, pools of cells were created by mixing
spleens from randomly-assigned CD-I mice of different litters (ages 3-10 days: 3 pools
of 10 pups each, and age 20 days: 9 pools of 3 pups each). However, unlike routine
mixed lymphocyte cultures in which cells of an individual (“responder”) are stimulated
by cells of another (“stimulator”), multiple responder cells were stimulated by multiple
antigens (pools of allogeneic spleens). Pooling of cell preparations was also required to
create sufficient cells for this culture experiment. However, only relatively small
responses were anticipated because individual clones of responder cells would be
represented by very few cells in this culture environment. Furthermore, extensive
reactivity could not occur due to the short culture period. Autologous control cultures
(no stimulation) consisted of cells from one adult (45-day-old) mouse.
Cultures were prepared from aliquots of mixed spleen cells. Aliquots contained a
constant number of Th cells (IxlO6 CD3CD4) previously quantified by
immunophenotype analysis. Thus cell cultures were normalized to cytokine production
per cell number between replicates and among groups. At the end of 24 hours
incubation, culture supernatants were collected and quantified for IL-4, IL-2 and IFNy
levels as outlined in Chapter 2.
Neonatal cells were expected to produce small amounts of cytokines in a 24-hour
culture period (antigen recognition phase) relative to adult cells. Minimal cytokine
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production was observed, IL-2 levels (Figure 4.1) were relatively low (poly-stimulated
adults, 1473±244 pg/mL), and there were recognizable and significant differences
(ANOVA, p<0.05) between ages, 10-day-old pups producing highest levels. The highest
production (dlO) was 4-fold greater than the autologous control. IFNy production (Figure
4.2) was also low (poly-stimulated adults, 12939±1745 pg/mL), but still there were
significant differences (ANOVA, p<0.05) between ages, and IFNy concentrations peaked
even earlier than those of IL-2. This relatively modest production at 5 days was nearly
twice that of adults, about six times higher than those reported by others (Adkins et
ah, 1993), and 7-fold greater than the autologous control. This variance may be
attributable to differences in cell culture composition (uncorrupted cell population ratios
versus contrived unnatural ratios of two isolated cell populations). Thus, it was
demonstrated here that lymphocytes of neonatal mice, given the appropriate conditions,
have the capacity to produce remarkably strong Thl inflammatory reactions in response
to allostimulation. In contrast, IL-4 could not be detected in cultures of cells from any
age. Yet Adkins et al. (1993) reported that cells of 4-day-old mice produced 400% of
adult levels, a response that they found had diminished to <200% in mice only 1 day
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Figure 4.1. Developmental profile of IL-2 production by spleen cells of CD-I outbred
mice in response to allogeneic stimulation in 24-hour mixed lymphocyte cultures. Each
culture was an aliquot containing IxlO6 CD3CD4 splenocytes. Control cells were
incubated in complete media only. Data are expressed as mean±SE of 3 samples for d310, and 9 samples for d20. Samples were comprised of pools of varying size of
randomized pups as follows: d3-10, 10 pups/pool; d20, 2-3 pups/pool. One d45 mouse
provided cells for autologous cultures. Statistical significance (p<0.05; df=5, F=3.86)
among ages was derived from one-way ANOVA with a Duncan's multiple range test, and
is indicated by "a" versus d3 and "b" versus d4.
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older. Given the antagonistic effects of Thl and Th2 cytokines (Mosmann et al., 1986),
the results of both studies can be explained. Furthermore, that these two studies found
opposing cytokine profiles can be explained by the use of different (contemporary versus
non-contemporary) APC sources and different mouse strains.
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Figure 4.2. Developmental profile of IFNy production by spleen cells of CD-I outbred
mice in response to allogeneic stimulation in 24-hour mixed lymphocyte cultures.
Control cells were incubated in complete media only. Data are expressed as mean±SE of
3 samples for d3-10, and 9 samples for d20 and 45. Pools were as described in Figure
4.1. Statistical significance (p<0.05; df=5, F=7.86) among ages was derived from one
way ANOVA with a Duncan's multiple range test, and is indicated by "a" versus d3; "b"
versus d4; and "c" versus d5.
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Developmental profile of cytokine production by single cell suspensions of spleen cells
(allogeneic mixed lymphocyte cultures) stimulated by ligation of CD3
The low level of alloreactivity noted in the first experiments may be due to any
one of several reasons. Indirect recognition of alloantigens (antigen processing and
recognition; Liu et al., 1993), cannot be achieved in 24 hours, and direct recognition by
naive cells of young individuals is likely to be less than optimal. As suggested earlier,
pools containing multiple members of disparate individuals had few cells of each clone
that could respond to a single antigen to produce cytokine. To demonstrate whether
neonatal cells are capable of directing mature Thl reactions, T cells were activated
through polyclonal stimulation (ligation of CDS cell membrane molecules with hamster
anti-mouse CD3 monoclonal antibody as done by Adkins et al. (1993) in addition to
alloantigen exposure (mixed lymphocyte spleen cells).
CDS ligation stimulated T cell production of adult-like Thl cytokine production
in pre-weanling mice. As found previously, both IL-2 (Figure 4.3) and IFNy (Figure 4.4)
productions varied significantly (ANOVA, p<0.05) between ages. Remarkably, IL-2 and
IFNy concentrations produced by 5-day-old mice were equivalent to, and higher,
respectively, than adult levels. These results contrast those reported by Adkins et al.
(1993) where high levels are not achieved until mice were 5-6 weeks old. In this
experiment, 5-day-old neonates were producing adult-level IL-2. IFN-y concentrations
had also increased significantly (ANOVA, p<0.05) by d5.
The sudden reduction in IFNy production after d5 is not clear. Perhaps abundant
production by younger pups reflects endogenous priming of T cells undergoing
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Figure 4.3. Developmental profile of IL-2 production by spleen cells of CD-loutbred
mice in response to allogeneic and polyclonal (CD3 ligation) stimulation in 24-hour
cultures. Each culture was an aliquot containing IxlO6 CD3CD4 splenocytes. Control
cells were incubated in complete media only. Data are expressed as mean±SE of 3
samples for d3-10, and 10 and 11 samples for d20 and d45, respectively. Pools were
described in Figure 4.1. Statistical significance (p<0.05; df=5, F=2.85) among ages, for
experimental (not control) data, was derived from one-way ANOVA with a Duncan's
multiple range test, and is indicated by "b" versus d4.
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Figure 4.4. Developmental profile of IFNy production by spleen cells of CD-loutbred
mice in response to allogeneic and polyclonal (CD3 ligation) stimulation in 24-hour
cultures. Each culture was an aliquot containing IxlO6 CD3CD4 splenocytes. Control
wells were incubated in complete media only. Data are expressed as mean±SE of 3
samples for d3-10, and 10 and 11 samples for d20 and d45, respectively. Pools were as
described in Figure 4.1. Statistical significance (p<0.05; df=5, F=6.74) among ages, for
experimental (not control) data, was derived from one-way ANOVA with a Duncan's
multiple range test, and is indicated by "a" versus d3; "b" versus d4; and "c" versus d5.
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peripheral self education. Self-memory differentiation of Thl cells is known to require
IFNy (Alferink et al., 1998). In sharp contrast, Th2 cytokine production (IL-4) did not
differ with age and averaged 82.5 pg/mL (SE=8.8), a level comparable to that found in
the previous experiments without CD3 ligation (data not shown). Thus, it has been
shown that, given an appropriate environment, neonatal mouse T cells are inherently
capable of producing adult quantities of Thl cytokines. Findings support the hypothesis
that the reported bias of neonatal T cells to selectively produce Th2 cytokines is the
result of an artificially contrived experimental paradigm.

Cytokine production by neonatal T helper cells receiving either one or two signals
Th cells, from adults, require both classical signals for activation, stimulation of
antigen receptor (signal 1) and co-stimulation of adhesion receptor (signal 2). When
antigen is presented to a T cell or when the T cell receptor is bound by an activating
antibody (CD3 ligation), a series of membrane and cytoplasmic events rapidly occur. In
addition to cytokine production, new cell surface molecules are expressed. Two of these
molecules, CD28 and CTLA-4 (Tinsley et al., 1992) have a common ligand, the B7
molecule that is expressed constitutively by dendritic cells and inducibly by activated B
cells, monocytes and macrophages (APC). Binding of B7 to CD28 or CTLA-4 is
important for the delivery of costimulatory signals required for full activation responses
of T cells to antigens. Thus, the next objective was to test the hypothesis the response
capabilities by neonatal Th cells was not equivalent to adult cells. The approach was to
use purified (“sorted” CD3CD4) Th cells, ligated with CD3 antibody, in culture with or
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without contemporaneous APC. Control cultures were sorted CD3CD4 and APC in
media.
Spleen cell suspensions were prepared from pooled spleens in the usual manner.
Th cells were then positively selected by sorting cells co-expressing CDS and CD4
molecules. From the remaining Th-depleted cells, antigen presenting cells were prepared
by negative sorting, as described in Chapter 2. T cells were cultured together with CDS
monoclonal antibody (signal 1 provided by alloantigens and CDS ligation) with and
without APC (signal 2).
Cytokine production by Th cells alone (“background” activity due to
allostimulation within pools; no CDS ligation or APC) was very low (IL-2, <15 pg/mL;
IFNy, <100 pg/mL) and did not change with age. IL-2 production was 300-fold and
IFNy >40-fold higher in cultures of Th cells with APC than by Th cells alone (data not
shown). IL-4 concentrations were nearly undetectable from Th alone, and <25 pg/mL in
Th+APC. Thus, it was established that neonatal Th cells require both signals to be
activated, and that these signals could be delivered by contemporary APC. It was also
apparent from these experiments that presentation of multiple disparate MHC antigens
(pooled Th+APC without CDS ligation) for only 24 hours may have resulted in the
phenomenon of T cell indifference (Zinkemagel & Kelly, 1997). Thus, to optimally
demonstrate cytokine production capabilities, polyclonal stimulation (CDS ligation) was
required.
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Developmental profile of cytokine production by sorted CD4 cells stimulated by
allogeneic APC and ligation of CD3
In these experiments, the model used by Adkins et al. (1993) was reproduced
(Th+APC+CD3 ligation) with three important exceptions. First, outbred rather than
inbred mice were studied to avoid genetic bias. Second, contemporary rather than adult
APC were employed to cooperate with Th cells as programmed in vivo. Third, APC:Th
ratio was 2:1 rather than <2:1, thus replicating in vivo conditions.
Cytokine production by neonatal Th cells matured within the first week of birth.
Significant (one-way ANOVA, p<0.05) age-related changes in IL-2 and IL-4 production,
but not IFNy, were observed. IL-2 (Figure 4.5) and IFNy (data not shown) productions
had reached 100% adult levels by d3 (days 0-2 not tested). IL-2 levels crested on dlO
while IFNy remained about the same (average, 1893+196 pg/mL; a tendency, p<0.16,
toward higher production by d45). On the other hand, IL-4 cytokine production was
within adult range on days 3-4, and again on d45 (Figure 4.6). Irrespective of age, IL-4
production was low (about 50% of adult). These results contrast sharply to those of
others: adult-like Thl cytokine production capacity is established in CD-I outbred mice at
a very young age (<3 days old), but not until adulthood (5-6 weeks) in BALB/c inbred
mice (Adkins et al., 1993).
It was clear that cytokine production was affected by culture conditions (culture
composition). Isolated (sorted) Th and APC did not function optimally, in spite of
polyclonal stimulation and higher ratios of APC-to-Th cells. Production of both Thl and
Th2 cytokines was greater in uncorrupted spleen cells than in purified Th+APC cultures
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Figure 4.5. Developmental profile of IL-2 production by sorted spleen cells of CDloutbred mice. Each culture contained 1x106 sorted CD3CD4 splenocytes, 2xl06 sorted
APC, and hamster anti-mouse CD3 monoclonal antibody. Data are mean±SE of n=6,d3;
n=4, d4; n=9, d5; n=7, dlO; n=10, d20; and n=l 1, d45. Pools were as described in Figure
4.1. Statistical significance (p<0.05; df=5, F=4.73) among ages was derived from one
way ANOVA with a Duncan's multiple range test, and is indicated by "b" versus d4; "c"
versus d5; and "d", versus dlO.

(two-way ANOVA, p<0.05) for most time points evaluated (Figure 4.7). The IL-2, IFNy
and IL-4 concentrations were different between these two types of culture (t-test, p<0.05)
on postnatal days 5 and 20, except IFNy which also differed on dlO and tended to be
different on d45 (p<0.07). The average percent difference in cytokine concentrations was
418% (IL-4), 286% (IL-2) and 1140% (IFNy) higher for in spleen cell preparations than
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Figure 4.6. Developmental profile of IL-4 production by sorted spleen cells of CD-I
outbred mice. Each culture contained 1x10° sorted CD3CD4 splenocytes, 2x10() sorted
APC, and hamster anti-mouse CD3 monoclonal antibody. Experiment and control
cultures, numbers of cultures, and pools are as described in Figure 4.5. Statistical
significance (p<0.05) among ages was derived from one-way ANOVA with a Duncan's
multiple range test, and is indicated by "c", versus d5; "d", versus dlO, and "e", versus
d20. For this data set, degrees of freedom were 5 with an F statistic of 3.19.
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Figure 4.7. Percent increase in cytokine production of single cell suspensions of spleens
compared to that of sorted Th and sorted APC from spleens of CD-I outbred mice (male
and female) at various ages. Data are expressed as mean percent increase in cytokine
production by unsorted spleen cell cultures over that produced by sorted Th/APC
cultures.

in isolated cells. The absence of some critical component(s) in the isolated cells most
affected IFNy production. Therefore, composition of cell mixtures significantly affects
cytokine production (age-related differences and magnitude of production).
In summary, the results of these culture experiments have established that
neonatal outbred mice possess the capacity to produce adult-like Thl cytokines. As
reviewed for adult cells, the immune system of neonates is a complex set of cellular and
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soluble components that is an integral part of a larger system (neuro-endocrine-immune).
If immune components are to be examined ex vivo, it is important to maintain (or
faithfully recreate) as much of the natural milieu as possible. Information generated from
isolated immune components can be readily misinterpreted, a principle validated in the
experiments described above. Different environments (spleen cell suspensions being
more similar versus sorted, purified Th/APC preparations being different than that found
in vivo), yielded entirely different results within the same animal model. Findings in the
experiments of Adkins et al, (1993) were further confounded by the mouse strain they
selected for defining cytokine production capabilities. BALB/c is an inbred strain
recognized for a bias to produce strong Th2 reactions and inappropriate Thl responses
due to an inborn failure to down-modulate IL-4 production (Reinier & Locksley, 1995).
In fact, it could be argued that any inbred strain might express dysregulation by virtue of
being inbred.

CHAPTER FIVE

IMMUNE MODULATION OF OFFSPRING BY MATERNAL
IMMUNIZATION (Leishmania major) DURING GESTATION

The objective of Specific Aim #4 was to test the hypothesis that maternal Thl
immune reactions experienced during gestation modulate fetal immune status. As such,
maternal Thl immune reactivity is predicted to advanced development of immune
phenotypes and Thl functional capabilities in progeny.
Pregnancy is reported to be a Th2-type phenomenon (Wegmann, 1984; Wegmann
et al, 1993); in other words, immune responses by the mother are biased to non
inflammatory humoral reactivity. Consistent with this view is the well-established
mechanism of providing passive immunity to the fetus through maternal antibody
transfer. However, humoral suppression in offspring (mice) of mothers immunized
during pregnancy (Yamaguchi et al, 1983; Watanabe et al, 1984; Iwata et al, 1986)
indicates that active immunization can have different effects, production and
transplacental transfer of specific antibody, or antigen-specific suppression. This latter
effect may be a consequence of passive transfer of antibody, but mediated by activated
CD4+ maternal T cells (Fuji! & Yamaguchi, 1992).
In addition to antibody-mediated humoral immunity, cell-mediated immunity is
required for survival, and Th 1 functions play a significant role in defending against
disease. Yet strong Thl reactions have been associated with pregnancy loss. Since
pregnancy is not normally a choice between surviving or dying for either mom or fetus,
82
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the maternal immune system must be capable of conducting lifesaving Thl responses
against pathogens while maintaining the fetal allograft.
Strong maternal Thl responses during pregnancy are deleterious to successful
delivery of viable offspring (Krishnan et al, 1996b). Even so, pregnancy can proceed but
progeny may be sensitized to the offending pathogen (Ratner et al, 1927; Field &
Caspary, 1971; Beer et al, 1911 \ Cramer et al, 1974; Horton & Oppenheim, 1976;
Herman et al, 1982); an observation supporting transplacental immunomodulation.
Although the mechanism for specific sensitization of offspring prior to birth has not been
delineated, maturation of neonatal immunity has been advanced. Whether advanced
functional maturation was the result of a change in immune cell phenotype profiles or in
cell-mediated immune responses is addressed in the present study.
Pregnant (gestational day 13) CD-I mice were inoculated with Leishmania major
extract (intraperitoneal). This immunization, designed to induce maternal inflammatory
(Thl) immune responses, was tested by challenging maternal spleen lymphocytes
(collected on the day of delivery) and assessing IFNy and IL-2 production. Based on
historical reports, it was hypothesized that progeny of these immunized dams would be
sensitized to L. major antigen and have an advanced repertoire of immune cell
phenotypes and Thl functional capacity.

Evaluation of maternal sensitization to Leishmania major inoculation
Optimization of the dose of Leishmania major for successful immunization of
CD-I mice was confirmed by assessing cytokine concentrations (IL-2, IFNy, IL-4) in

84

serum and in supernatants from spleen cells in culture after in vitro challenge with L.
major (recall). At the end of incubation, the cell culture supernatants were collected and
assayed for IL-2, IFNy and IL-4.
Pilot study. Serum IL-2 and IL-4 concentrations were undetectable, Table 5.1;
while IFNy, although measurable, was not different between groups. IL-2 concentrations
in cell culture supernatants from pregnant animals were significantly (t test, p<0.05)
increased in experimental compared to control animals. Similarly, IL-2 concentrations in
non-pregnant animals were significantly higher (p<0.05) than controls. In contrast to IL2, IFNy concentrations were no different between cultures of controls and experimental
animals. In culture supernatants, no IL-4 was detected in any group.

Table 5.1. Pilot study of cytokine concentrations (mean±SE) in serum (primary
immunization) and from supernatants of spleen cell cultures (recall study) of L. majorimmunized pregnant and non-pregnant CD-I mice, (has = below assay sensitivity)

Non-pregnant, Saline (n=2)
Non-pregnant, L. major (n=4)
Pregnant, Saline (n=3)
Pregnant, L. major (n=3)

Cytokine Concentration (mean, pg/mL±SE)
Supernatant
Serum
IL-4
IL-2
IL-4
IL-2
IFNy
IFNy
has
has
5
has
329±57 has

has
has
has

486+31
389±70
379±50

has
has
has

210±57
has
145±78

13±13
13±13
99±44

has
has
has

This pilot study confirmed that in vivo treatment with L. major extract could elicit
a Thl immune response (IL-2 and IFN ) in both pregnant and non-pregnant CD-I mice.
It also confirmed that 16.6 pg L. major extract /well was sufficient antigen concentration
for in vitro testing of sensitization.
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To further optimize in vivo and in vitro doses of L. major antigen, a twodimensional array was set up: the first array was for the in vivo dose and included 75,
125, and 250 pg/mouse of L. major, saline-treated mice served as controls. The second
array tested 0 (saline), 8, 16.6 and 33 pg/mL of L major antigen as in vitro antigen
concentration. Supernatants from cell cultures were evaluated for IL-2 concentrations
only, since data from the previous pilot study revealed that IL-2 was the relevant cytokine
produced by these mice to L. major extract (Table 5.2).

Table 5.2. IL-2 concentrations produced by spleen cells from adult female CD-I mice
challenged in vitro with various doses of L. major eight days prior to in vitro challenge.
Concentrations are expressed as mean±SE (n=3).

Immunization
Dose
Saline
75 pg/mouse
125 pg/mouse
250 pg/mouse

Concentration of Leishmania major added to cultures
Complete
33 pg/well
16.6 pg/well
8 pg/well
Media
61.6 ± 12.9
93.6 ±63.1
94.9 ±25.7
1.9± 1.1
560.9
± 154.7
416.7
±
141.5
525.4 ±227.8
106.2 ±37.8
340.4 ± 148.4
318.9± 121.4
310.7 ± 119.7
265.1 ± 141.5
252.0 ±71.0
259.6 ±99.8
217.4 ±85.7
13.9 ± 13.3

From these data, the optimal dose for in vivo administration was determined to be
between 75 and 125 pg/mouse, and the in vitro dose between 16.6 and 33 pg/well. Thus,
100 pg/mL and 20 pg/well concentrations were chosen for use in vivo and in vitro.
respectively.
Maternal modulation of neonatal immunity. Maternal sensitization was
demonstrated by a tendency of higher IL-2 concentrations by splenocytes of experimental
dams compared to controls dams. To confirm immunizations of dams in the modulation
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experiments, spleen cell suspensions (1x106) from inoculated (L. major) and control
(saline) dams were challenged (72-hour culture) with L. major extract (20

g).

Supernatants were analyzed for cytokines (IL-4, IL-2 and IFNy). IL-4 production was
below detection (Table 5.3) and IL-2 production was not significantly affected by
treatment of dams with L. major compared to that in controls. IFN

concentrations did

not differ between groups. Although, some maternal sensitization was suggested, Thl
responses were weak, a likely consequence of the immunization schedule. Treatment
with L. major was abbreviated compared to chronically sensitized or infected mice where
strong inflammatory reactions are documented (Krishnan et al., 1996b) and have induced
resorptions and premature delivery of viable offspring. Inflammatory cytokine
production did not result, indicating that dams failed to respond in a Thl-type manner. It
is not known whether they produced Th2 cytokines.

Table 5.3. Cytokine production by spleen cells of CD-I dams inoculated on gestational
day 13 with Leishmania major extract or saline. Spleen cells, collected on day of
delivery, were challenged in vitro (IxlO6 cells + 20 pg extract) for 3 days. Supernatants
were assayed for IL-4, IL-2 and IFNy concentrations, (nt = not tested)

Saline (n=3)
L. major (n=10)

IL-4
nt
nt

Cytokine (pg/mL±SE)
IL-2
84±77
226±62*
* Student’s t-test, p=0.2

IFNy
530±147
618±551
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Ontogenic development of immunophenotypes in progeny born to dams inoculated with
Leishmania major
The developmental profiles of immune cells (proportions and absolute numbers)
of male and female progeny bom to experimental dams were compared to progeny of
control dams. Blood and spleen cells were assessed as described previously (WBC,
lymphocytes, B, NK, T, T helper/inducer, T cytotoxic/suppressor, naive Th, and memory
Th; in mice 3, 4, 5, 10, 20 and 45 days of age). Significant (p<0.05) temporal effects,
overall comparison of gestational treatment {L. major) versus control, and association
between treatment effect and age were evaluated by two-way ANOVA. Group
differences per age were evaluated with the Student’s t-test.
WBC and lymphocytes. WBC and total lymphocyte counts in blood_of 45-day-old
experimental progeny were lower than those in control animals. In blood, the WBC on
day 20 was 1.5-fold greater than control cohorts (two-way ANOVA, interaction between
factors, p<0.05). However, by day 45, WBC of experimental progeny were significantly
lower (2-fold) from those of control progeny (Student’s t-test, p<0.05). Absolute
numbers of lymphocytes in blood of experimental progeny were significantly lower only
on postnatal day 45 compared to controls (two-way ANOVA, interaction between
factors, p<0.05). In contrast to blood, in spleen, treatment effects were observed only in
absolute numbers of lymphocytes; these were 1.3-fold higher on day 45 than in control
mice (Student’s t-test, p<0.05). Thus, treatment effects were observed but they were not
apparent until after weaning. Proportions of lymphocyte subsets in offspring bom to
experimental or control dams were then compared for treatment effects.
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Proportions of immune cell phenotypes in blood
In blood of experimental progeny, proportions of B cells were greater (Figure 5.1,
panel A) while T cell subsets and NK cells were lesser than those in control progeny
(Figure 5.1, panel B). T cell effects were reflected in decreased Tc/s cells (two-way
ANOVA, main effects, treatment versus control, p<0.05), that were lowest on d45
(Student’s t-test, p<0.05). Proportions of NK and naive Th (CD62p0S CD44low) in blood
were significantly affected, changes dependent on age (two-way ANOVA, interaction
between factors (age versus treatment), p<0.05). NK proportions in experimental animals
were lower on d3 and higher on dlO (Student’s t-test, p<0.05), and tended (t-test, p-0.07)
to be higher on d45 when compared to control progeny of the same ages. In contrast,
proportions of naive Th were significantly lower on d4 (Student’s t-test, p<0.05) and
tended (p=0.12) to be higher on d45. Thus, Leishmania major inoculation during
pregnancy had a modulating effect on the proportions of specific immune cell phenotypes
in circulation.

Proportions of immune cell phenotypes in spleen
Proportions of splenic phenotypes in experimental progeny were increased
compared to control progeny (Figure 5.2). Main treatment effects were observed across
all ages (two-way ANOVA, main effects, treatment versus control group, p<0.05) for
CD 19, CD3, CD4 and CDS. Overall, B cells were higher and T lower in experimental
pups. Proportions of T cells on d20 and Tc/s cells on d20 and d45 were significantly
below normal (Student’s t-test, p<0.05). NK cells were strongly affected by treatment,

89
Panel A
’O

o

X!

a
Q

U

63 " |
58 -

53 '
48-

09

43 '

%u

38 '

W

® Control
—l-t— L. major j

33 28

4

3

5

10

20

45

Age (days)
Panel B
18
major

16
T3

eo

15

A

14

•k

Control

17

a 13
o

12

H 11
10
9

f

8
3

4

5

10

20

45

Age (days)

Figure 5.1. Proportions of B (CD 19, Panel A) and T c/s (CDS, Panel B) cells in blood of
pups at various ages delivered from dams treated during gestation with saline or
Leishmania major (100 pg/mouse i.p. in saline). Data points are mean±SE of 5
samples/age, except 6 for d20 saline group; and 5 samples/age for L. major. Samples
represent pools of randomized pups (d3-10, 5-14/pool; d20, 2/pool; d45, 1 pup).
Statistical significance (p<0.05; df=l; F=4.18 for CD19; and F=4.13 for CDS) for
treatment effects among groups was derived from two-way ANOVA. Post-hoc analyses
were performed with Student’s t-test to reveal differences among groups per age (*,
p<0.05). See statistical analysis section in Material and Methods (Ch. 2) for further
details. At some ages, symbols encompass area of SE bars.
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Figure 5.2. . Main treatment effects were observed across all ages (two-way ANOVA,
main effects, control versus treatment group, p<0.05) for proportions of B (CD 19, Panel
A), T (CD3, Panel B), Th (CD3CD4, Panel C) and Tc/s (CD3CD8, Panel D) in spleen of
pups of various ages. Progeny was delivered from dams treated during gestation with
saline or Leishmania major (100 pg/mouse i.p in saline). Data points are mean±SE of 5
samples/age. Samples represent pools of randomized pups (d3-10, 5-14/pool; d20,
2/pool; d45, 1 pup). Statistical significance (p<0.05) for treatment effects among groups
was derived from two-way ANOVA. These analyses generated F statistics of 9.8
(CD 19), 7.7 (CD3), 10.3 (CD4) and 16.4 (CDS) with 1 degree of freedom. No significant
group interaction was observed for all. Post-hoc analyses with Student’s t-test revealed
differences among groups per age: d4 (CD 19), d20 (CD3 and CDS). See statistical
analysis section in Materials and Methods (Ch. 2) for further details. At some ages,
symbol area encompasses SE bars.
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and dependent on age (two-way ANOVA, interaction between factors, p<0.05). On dlO
the NK population was 1.7-fold higher than controls (Student’s t-test, p<0.05). In
summary, proportions of B cells in blood and spleen were higher, while T cells were
lower in experimental progeny compared to control progeny.

Numbers of immune cell phenotypes in blood
Absolute numbers of blood cells in experimental progeny were lower than control
progeny, including T, naive Th (CD62LposCD44low) and memory Th (CD62Lneg
CD44h,gh), Figure 5.3, and was the main treatment effect (two-way ANOVA, main
effects, control versus treatment group, p<0.05). Furthermore, decreases in numbers of
all subsets of T cells were dependent on age (two-way ANOVA, interaction between
factors, p<0.05). T cells and T cell subsets were 1.9- to 3.4-fold lower than controls on
d45, but Tc/s rose 1.5-fold higher on d20 (Student’s t-test, p<0.05). In general, L. major
inoculation during gestation decreased the number of blood immune cell phenotypes in
progeny, but most of the effect was not apparent until adulthood. The specific time when
the effects were more noticeable post-weaning could not be determined because data
between d20 and d45 was not collected.

Numbers of immune cell phenotypes in spleen
The principal treatment effects observed in spleen cells were higher NK and naive Th
cells (Figure 5.4; two-way ANOVA, main effects, control versus experimental progeny,
p<0.05). Additional effects of treatment, significantly dependent on age (two-way
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Figure 5.3. Absolute numbers of Th (CD4, panel A), memory Th (CD62LnegCD44hlgh,
panel B) and naive Th (CD62posCD44low, panel C) cells in blood of pups of various ages
delivered from dams treated during gestation with Leishmania major (100 pg/mouse i.p.)
or saline. Data points are mean±SE of 5 samples/age, except 6 for d20 in saline group;
and 5 sample/age in L. major group. Samples represent pools of randomized pups (d310, 5-14/pool; d20, 2/pool; d45, 1 pup). Statistical significance (p<0.05; df=l; F=4.9 for
Th; 2.4 for naive and 5.3 for memory) for treatment effects among groups was derived
from two-way ANOVA. Interaction between treatment and age suggest that effects are
seen only on d45 (F statistic: naive=2.4 and memory=5.3; df = 5, p<0.05). Post-hoc
analyses with Student’s t-test (two-tail) revealed differences among groups per age (*,
p<0.05; df=8; t statistic of -3.35 (CD4), -3.64 (naive), and -3.64 (memory). See statistical
analysis section in Materials and Methods (Ch. 2) for further details. At some ages,
symbols obscure SE bars.
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ANOVA, interaction between factors, p<0.05), were greater numbers of NK, T, and Th
naive and memory cells than found in control pups. Absolute numbers of naive and NK
cells on d45 were significantly higher (Student’s t-test, p<0.05), 140% and 200%,
respectively, than those in control mice. Thus L. major treatment during pregnancy had
an up-regulating affect on populations of T, naive and memory Th, and NK cells in
spleens of progeny and this affect was pronounced at post-weaning age. Missing data (no
assessment between d20 and d45) prevents accurate determination of when these changes
actually manifest.

Ontogeny of cytokine response capabilities of the progeny born to Leishmania major
treated dams
Functional capabilities of splenic lymphocytes were tested as previously
described (CD3-ligated mixed cell cultures and cytokine levels in supernatants, Chapter
4). IL-4 production did not differ between L. major- and saline-treated groups. In
contrast, Thl cytokines decreased in response to challenge by specific antigen. IL-2 was
significantly lower (p<0.05) on d45. The modulating effects ofZ,. major inoculation on
IFNy production was associated with age (two-way ANOVA, interaction between factors,
p<0.05). Post hoc comparisons with Student’s t-test revealed significantly (Figure 5.4,
Student’s t-test, p<0.05) lower IFNy concentrations on d5. A decrease rather than
increase in Thl responses observed in this experiment indicates that dams may have been
tolerized rather than immunized, a response that could have been transferred to progeny.
In the present study, dams were inoculated on gestational day 13; in at least one
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Figure 5.4. Natural killer (NK, panel A) and naive Th cells (CD62LposCD44low, panel B)
in spleens of pups of various ages delivered from dams treated during gestation with
saline or Leishmania major (100 ug/mouse i.p. in saline). Data points are mean±SE of 5
samples/age, except 6 on d20 in saline group; and 5 sample/age for L. major. Samples
represent pools of randomized pups (d3-10, 5-14/pool; d20, 2/pool; d45, 1 pup).
Statistical significance (p<0.05; df=5; F=8.27 for NK and 16.2 for naive) for treatment
effects among groups was derived from two-way ANOVA. Post-hoc analysis with
Student’s t-test (two-tail) to reveal differences among groups per age (*, p<0.05; df=8; t
statistic of 2.99 (NK) and 5.4 (naive). See statistical analysis section in Materials and
Methods (Ch. 2) for further details. At some ages, symbols obscure SE bars.
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Figure 5.5. IFNy (top panel) and IL-2 (bottom panel) production (stimulated) by spleen
cells of CD-I outbred mice (male and female) delivered from dams treated during
gestation with saline or Leishmania major (100 pg/mouse i.p in saline). Each culture
contained 1x106 CD3+CD4+ splenocytes and hamster anti-mouse CD3 monoclonal
antibody in complete media. Control cells were cultured in media only. Data are
expressed as mean±SE of samples (control: d5=4, dl0=3, d20=10, d45=l 1; experimental:
d5=7, dl0=7, d20=3, d45=5). Samples in stimulated cultures were pools of randomized
pups (d5 and 10, 10/pool; d20, 3/pool; d45, 1 pup). Statistical significance (p<0.05;
df=3; F=3.6) between groups was derived from two-way ANOVA. Post hoc analyses
with Student's t-test (two-tail) revealed differences among groups per age (*, p<0.05;
df=9 (IFNy) and 14 (IL-2); t statistic of -2.63 for IFNy and -2.45 for IL-2). See
statistical analysis section in Materials and Methods (Ch. 2) for further details.
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study using a different model (Beer et al., 1977), immunization between 13 and 15 days
gestation induced a state of tolerance. Furthermore, the soluble, non-pathogenic nature of
the L. major extract may have directed the ensuing immune response down the Th2 arm
(tolerance) of immunoreactivity. Yet progeny of these treated females demonstrated
significant shifts in ontogeny of immune cell populations in splenic compartments
(Chapter 4). Functions of these cells, e.g., production of cytokines, may have been
modified by the abundant immune products delivered through suckling (Newman, 1995),
thus explaining the observation of more significant differences being noted post weaning.
Data of this study have documented that induction of immune reactivity in dams during
gestation induces modulation in cytokine response capabilities of offspring.

Evaluation of sensitization to Leishmania major in progeny
To determine whether progeny of inoculated dams had developed antigen-specific
sensitization, spleen cells were challenged (72-hour culture) with L. major extract (20
pg). Supernatants were then analyzed for cytokines (IL-4, IL-2 and IFNy). No cytokines
were detected in progeny from saline or L. major treated dams.. These data indicate that
the pups bom to experimental dams may not have been sensitized to L. major in utero.
In summary, dams inoculated once during gestation with extracts of Leishmania
major were minimally reactive (low IL-2 production) to antigen challenge, probably a
consequence of using a soluble antigen preparation in an acute immunization schedule in
a pregnant (a Th2-prone) individuals. This result was a consequence of employing an
immunization program designed to avoid strong Thl reactivity that would jeopardize
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fetal survival. Despite weak reactivity by maternal spleen cells (data of pilot study
indicated that dosage was adequate to bring about significant Thl responses), significant
modulation was observed in lymphocyte profiles of their progeny. There were significant
increases in splenic NK and T cell numbers at maturity (Figure 5.4), and significant
decreases in IL-2 (d45) and IFNy (d5) production by activated spleen cells compared to
controls. Taken together, these data support the hypothesis that immune events
experienced by the mother during gestation can modulate the pattern of immune
development (cell phenotypes and cytokine response capabilities) in the offspring, thus
satisfying the objective of Specific Aim #4.
Expectations were that this experiment would result in up-regulation of Thl
function; instead, it appears that Th2 functions may have been induced. Spleen cells of
progeny decreased production of IL-2 and IFNy. It is possible that a state of tolerance
rather than inflammatory reactivity was induced in dams and pups; evidence by the
decrease in Thl cytokine production in response to polyclonal stimulation. The decrease
in Thl cytokine production can be explained by taking into account three facts: 1, soluble
antigens primarily induce Th2 reactions (Zinkemagel & Kelly, 1997), inoculation in mid
gestation can lead to tolerance (Beer et al., 1977); 3, down-regulation of Thl-type
cytokines is a consequence of tolerance induction (Chen & Field, 1995). If dams had
been tolerized, and information of this immune status had passed to their progeny, a shift
in cytokine profile away from Thl would be expected. However, this conclusion cannot
be validated with the current data, and further experimentation is required to explore the
influence of milk immune products acquired through suckling.

CHAPTER SIX
DISCUSSION AND CONCLUSIONS

Immunophenotype development
Evidence from these studies indicate that trafficking of immune cells into the
bloodstream, and seeding of secondary lymphoid organs, e.g., spleen, are developmental
milestones in the mouse. Exportation of B and T cells from bone marrow and thymic
compartments into blood is pronounced by postnatal dlO and maturation of cell-mediated
immunity is achieved by d20 in an outbred mouse (Figures 3.2 & 3.4). Before d20,
critically low numbers of B, memory Th, and Tc/s cells may, in part, define the neonatal
window of immaturity in this rodent. Population of lymphoid tissues with large numbers
of immunocompetent cells, and peripheral education to self antigens is prerequisite to
enrolling the immune system in defense functions. Establishing a mature yet self-tolerant
cellular immune system is an essential first step in immune maturation (Thanchot &
Rocha, 1997); interruption of this process results in pathologies such as autoimmunity
(Hirokawa et al, 1988). This self education cannot proceed safely in a milieu of
inflammatory products, and it has been established that the earliest immune cells favor
suppressor activity (Maier et al., 1987; Morimoto et al., 1985; Oseroff et al., 1984), thus
paving the way for Th2-biased activities. In this study, it was shown that Th2 cytokine
production (IL-4) is prevalent on postnatal days 3 and 4 (Chapter 4, page 72), indicating
that Th cells of the second type dominate immune activity in the earliest stages of
establishing cellular immunity. The temporal advance in proportions of T cells on
98
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postnatal day 5 found in Thl-prone C57BL/6 mice is consistent with premature closure
of immaturity that brings about full immune response capabilities of the inflammatory
type. Comparison of this mouse strain with the outbred CD-I strain provides an
indication that early thymic exportation of Th cells underlies advanced Thl responses in
neonatal C57BL/6 mice. In contrast, delayed thymic exportation to secondary lymphoid
organs prevents inflammatory immune reactivity (Yagi et al, 1996) and is predicted to
forestall closure of the window of immune system immaturity. It can be speculated that
such a delay occurs in Th2-dominant DBA/2Cr and BALB/c mice, strains that are
markedly susceptible to murine candidiasis (Romani et al, 1993) and Leishmania major
infections (Fowell et al, 1998), both of which require Thl cellular responses for
resolution. Thus, appropriation of sufficient numbers of mature immunophenotypes by
d20 may be conceived to establish precursors essential to mature immune function.
Attaining this critical threshold of immunophenotypes may effectively close the
“window” of compromised inflammatory reactivity and eliminate the bias towards
immunotolerance in neonates.
Over 40 years ago, Billingham, Brent and Medawar (1953) first described the
window of immaturity in allogeneic acceptance by neonatal mouse. Recently, Alferink et
al. (1998) found that neonatal induction of tolerance requires migration by naive T cells
to peripheral tissues. The present data also suggest that trafficking of naive cells is
increased during the neonatal period. Up to dlO, prevalence of naive cells (no memory
cells) in blood and spleen apparently underlies the recognized neonatal predisposition to
allograft tolerance.
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Development of critical numbers of memory Th cells by d20, especially in spleen.
may result from pathogenic challenge in the neonatal period. However, Forni et a. I
(1998) have found that Th cells increase in developing germ-free mice. Since Th
differentiation was not studied, it is not known whether memory Th cell numbers increase
in absence of xenogeneic challenge. In the present study, memory Th cells differentiate
before d20 (accounting for 12% of all Th cells; Figure 3.6). Postnatal memory Th
development may be the result of exposure to both somatic self and xenogeneic epitopes,
a consequence of peripheral education of thymic emigrants (De Albuquerque et al, 1994;
Thanchot & Rocha, 1997; Alferink et al, 1998). Therefore, differentiation of
immunologic memory may be considered part of a mechanism terminating neonatal
acceptance of antigens as “self.”
Profiles of lymphocyte development in this study appeared to differ from a
previous report. King et al. (1991) found that splenic B and T cell subsets only gradually
attained adult proportions by d35; yet in this study, a sharp increase in T cell proportions
were noted within the first ten days. A direct comparison with their study was not
possible because they analyzed cells relative to total leukocytes; in contrast in the current
data, cells were analyzed relative to lymphocytes. Reanalysis of current data in
proportion to total leukocytes (their methodology) rather than lymphocytes revealed a
gradual increase of Th cells from birth to adulthood. Thus, profiles of the King et al
study and the present effort are congruent. Evidence collectively supports the hypothesis
that an increase in rate and amplitude of thymic exportation during the first 2 weeks is a
critical step in establishing a mature cellular immune system.
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Thymic emigration appears to continue beyond the neonatal period. Thanchot
and Rocha (1997), using transgenic cells, traced a continuous exportation of naive Th
cells into splenic compartments well into adulthood. Yet emigration in the adult was
maintained at substantially lower levels than in neonates. Continued exportation of T
cells to the periphery beyond d20 is required for maintenance of immunological memory
(De Albuquerque et al, 1994). Profiles of Th subsets in the current study are consistent
with these observations; naive T cell proportions in blood and spleen are antecedent to
increases in memory cells (Figure 3.6; left panels). Therefore our data confirm and
further define, particularly in the critical first few days postpartum, the dynamics in
lymphocyte trafficking from primary to secondary lymphoid organs.
To understand the significance of neonatal cell trafficking, proportions and
numbers of each population in spleen are considered together. T cell profiles in spleen
reveal a bimodal distribution. The first peak, occurring before d20, is a result of thymic
output without peripheral expansion (cell trafficking, seen in the blood profile) and is a
pool of peripheral T cells representing a diversity of available repertoires (Modigliani et
al, 1994). However, the second peak, noted after d20, indicates that continued
immigration (De Albuquerque et al, 1994) is accompanied by significant clonal
expansion (Modigliani et al, 1994). A rapid gain in splenic memory Th cells (Figure 3.6,
bottom left panel) establishes a memory repertoire, permitting delivery of the robust
immune responses of an immunocompetent adult, while maintaining the original
repertoire. In summary, findings support the hypothesis that development and
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peripheralization of critical numbers of Th cells and development of a memory repertoire
define immunocompetence, and close the window of immaturity.
During the first postnatal days, memory Th cells are sparse and unlikely to
amplify inflammatory responses in vivo. Large proportions of B and naive Th cells
predispose conditions for alloantigen acceptance (Beck et al, 1994). This pattern of
peripheralization, however, is subject to genetic influence, a phenomenon observed in
C57BL/6 mice. Advanced peripheralization of phenotypes, while not explaining the
inflammatory bias of this strain, suggests premature closure of immaturity compared to
outbred mice. Based on observed differences in immune capabilities of clinical cases and
two mouse models, selective advancement (or delay) of this normal process of neonatal
immune development in predictable and quantitative ways could be advantageous. That
is, an infant’s vaccination schedule or immunosuppressive therapy for organ
transplantation could be optimized based on the relative state of immune competence and
preponderance of Th cell functional capacity to develop tolerance or aggression. In
addition, understanding maternal regulation of perinatal immunity will advance pediatric
assessment practices, improve the efficacy of treatment strategies for sick newborns and.
ultimately, reduce infant morbidity and mortality. Manipulation of the fetal milieu
(through induction of maternal immune system reactions), subject of Specific Aim #4
discussed below, produced changes in the normal developmental pattern of immunity in
offspring.
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Cytokine production during development
Assessment of cytokine production in outbred mice demonstrated that Thl
capability is achieved within the first week of life. By d5, splenocytes produced IL-2 and
IFNy in response to allogeneic stimulation in vitro (Chapter 4, Figure 4.1 and 4.2).
Production capability at this age was yet more evident when cells were maximally
stimulated (polyclonal) through CD3 ligation in the presence of allogeneic antigens
(Chapter 4, Figure 4.3 and 4.4). Wakil et al. (1998) have shown that IFNy, required to
maintain IL-12 responsiveness by T cells, is requisite for establishing Thl activity. In
this study, IFNy production by T cells of 5-day-old neonates clearly indicates that
capacity for Thl responses is present in immune cells of the young neonate. However,
expression of adult capability at this young age was solicited by extraordinary means.
indicating the presence of other immunoregulatory controls safeguarding against
inappropriate aggressive activity.
These findings do not support the reported inability of neonatal cells to produce
Thl cytokines. Previously, Adkins et al, (1993) reported that neonatal T cells are
intrinsically unable to produce IL-2 and IFNy until d45, a finding in conflict with data of
the present study. At least two explanations of this discordance can resolve the
discrepancy between Adkins’ and the present findings. First, Adkins et al, (1992 and
1993) used APC from adult mice to costimulate neonatal T cells in the presence of CD3
ligation. Second, they used an APC:T ratio lower than that normally found in neonates.
Contemporary APC used in that same ratio (<2:1) solicited significant Thl cytokine
production in our work. Thirdly, Adkins et al. (1992 and 1993) studied cytokine
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response capabilities of neonatal BALB/c mice. This mouse strain is biased towards
production of IL-4 (a Thl antagonist) and expresses inappropriate Thl responses (Reiner
& Locksley, 1995), designating this model as less than ideal for studies of maturation of
Thl responsiveness.
Further confounding an understanding of neonatal cytokine production are the
artifacts imposed by in vitro investigations. APC function has been reported to be
immature in neonates (Trivedi et al, 1997; Hunt et al, 1994; Clerici et al, 1993). Yet
others report an increased efficiency in neonatal APC function over those of adults (van
Tol et al, 1983; 1984a; 1984b; Marwitz et al., 1988). This inconsistency in reports of
neonatal APC function caused us to approach this investigation from two directions.
First, function of T cells was studied in context of relatively uncorrupted splenocyte
preparations, thus preserving natural APC-to-T cell ratios. Second, in sorted-cell
experiments, contemporary APC and Th cells were co-cultured. Although age-related
changes in cytokine production were observed in both kinds of cultures, the magnitude of
cytokine production was 300 to 1100-fold higher in uncorrupted spleen leukocyte than
sorted splenocyte cultures. In non-sorted cell cultures, highest concentrations of IL-2 and
IFNy were produced by 5-day-old pups (Figure 4.3 & 4.4) whereas optimal production in
sorted cell cultures was not achieved until pups were 10 days of age (Figure 4.5 & 4.6).
Thus, composition and ratio of cooperating cell populations are critical ingredients in
achieving natural regulatory immune processes, and are components shown in this study
to be of critical importance for eliciting age appropriate immune responses. These
findings are consistent with Ridge et al. (1996) who suggested the APC-to-virgin T cell
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ratio determines which type immune response is produced by neonatal T cells. The
significantly greater cytokine production realized by non-sorted cells is likely a result of
providing an optimal environment of cell ratios, other cells than APC and Th such as
Tc/s, and cell products such as neuropeptides, hormones and regulatory cytokines.
The present data are also consistent with reports (Delespesse et al, 1998) that
cytokine milieu together with accessory cell function (strong or weak CD28
costimulation) determine whether T cells mature to Thl or Th2 effectors at any age. In
more recent work, Adkins et al. (1994) have attributed the inability of neonatal T cells to
achieve adult-like Thl cytokine production to inefficiency of accessory cell stimulation.
Double ligation (CD3 and CD28) of neonatal T cells to deliver classical activation of
aggressive function (signal 1+2) achieved induction of adult cytokine production in
neonates equivalent to that induced by contemporary APC in this study. Use of
contemporary APC in cultures of CD-I mouse cells resulted in equivalent or greater than
adult Thl production by 5-day-old mice. Use of cell ratios reflecting a contemporaneous
environment established that neonatal cells competently produce Thl cytokines. Optimal
production of inflammatory cytokines by day 5 affirm that neonatal splenic APC are
efficient collaborators of neonatal T cells, an illustration of parallelism in ontogenic
evolution.
Patterns of Thl cytokine production are a reflection of available phenotypes.
Before d5, there are very few memory cells in spleen, while adult spleens contain manyfold greater numbers. Memory cells migrate to spleen after down-regulating CD62L
expression (Forsthuber et al, 1996), and have increased capacity to produce Thl and Th2
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cytokines compared to naive cells (Bradley et al., 1992). In certain conditions in young
mice, naive Th produce more IL-2 than memory Th (Kurashima & Utsuyama, 1997). In
neonates, memory cells are generated in response to foreign and self (peripheral) antigens
(post-thymic education; Alferink et al., 1998). In this study, high thymic output of naive
T cells was observed between d3 and dlO. Thus these early thymic naive emigrants may
be involved in self-antigen recognition, an activity that would induce changes in cytokine
responses. Cells found in spleen of d5 pups may be the first thymic emigrants having
processed peripheral tissue antigens (peripheral tolerization).

Maternal immune modulation of developing immune cell phenotypes
The hypothesis that maternal Thl-type immune responses during gestation
can modulate the pattern of immune development (cell phenotypes and cytokine
response capabilities) in offspring was tested by inoculating pregnant dams with
Leishmania major extract. Immune cell phenotypes in blood and spleen and cytokine
responses of splenocytes were studied as indices of immune character and function in the
pups born to these dams. Sensitization of pups to L. major was tested in vitro using a
“memory recall” assay. It was anticipated that the immune phenotypes and cytokine
profiles of these pups would be accelerated in these pups as compared to controls,
expectations based on clinical observations in infants (Nehlsen-Cannarella & Chang,
1992). Profiles of neonatal immune cell phenotypes have been used as indices of
immune maturation (Harp & Sacco, 1996), so these and function of T helper cells were
assessed.
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Maturational profiles of immune phenotypes during the neonatal period (Ig+ B,
Thy-1, CD4, CDS cells) have been reported to be seemingly preprogrammed. Harp and
Sacco (1996) produced active infection (Cryptosporidium parvum) in young postnatal
animals and observed unchanged patterns of immune cell development; on first
examination, these findings seem to indicate presence of an internal clock unaffected by
postnatal events. To date, no evaluation of the impact of maternal immune experiences
during gestation on immune development in progeny has been reported.
In this study, we effected changes in programming of neonatal immune
development by inducing maternal immune modulation (response to Leishmania major
inoculation). In progeny of these dams, maturational profiles of immune cells in both
blood and spleen were changed throughout the neonatal period, and these changes were
more pronounced after weaning. In blood, leukocytes and lymphocytes of experimental
progeny were lower than in control progeny and this difference was markedly noted on
day 45. In contrast, spleen lymphocytes of experimental progeny were higher on d45
compared to control progeny, suggesting a homing of circulating lymphocytes to splenic
compartments. That effects of maternal immune experience during gestation are most
apparent in progeny reaching adulthood may be a result of yet further maternal-mediated
immune regulation perhaps through passive transfer of immunoglobulins during late
gestation and via milk during the suckling period (Newman, 1995). Some of these
regulatory products in milk include antibodies, cells (lymphocytes, macrophages and
neutrophils), lactoferrin, B12 binding protein, bifidus factor, fibronectin, gammainterferon, hormones, growth factors, and lysozyme.
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Immune modulating effects were evident in profiles of specific cell phenotype
numbers in both blood and spleen. In blood the suppressive effect persisted as overall
low numbers of T and T cell subtypes, an effect accentuated on d45. In contrast.
developmental profiles of spleen T, naive and memory Th, and NK cells were
significantly increased on d45. Thus, it appears that T and Th subsets in circulation may
have increased homing activity to spleen lymphoid compartments.
Helper cell function, Thl cytokine response capabilities, of offspring were
affected by maternal immune modulation during gestation. This was evident in the lower
production of IFNy by d5 neonatal cells compared to control progeny. Also, IL-2
production by experimental progeny was lower on d45. Neonatal Th2 response
capabilities were not affected by maternal inoculation during gestation. IL-4 production
by experimental progeny was the same as that of control progeny.
The present study raises the possibility that maternal immune experiences may
equip offspring in utero to defend against specific pathogens encountered outside the
womb while preventing vertical transmission of infection. If this had been the case,
sensitization of experimental offspring to Leishmania major antigen would have been
induced. The memory recall experiments, performed by challenging spleen cells of
offspring with Leishmania major extract, produced no detectable cytokines after three
days of culture. These results indicate lack of sensitization to Leishmania major in the
offspring. Alternatively, absence of response may be due to challenging neonatal cells
with too high antigen concentration; it has been recognized that neonatal antigen
presentation is 100-fold more efficient than adults (van Tol et al., 1983; 1984b). The
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dose of L. major antigen used in the memory recall assays had been optimized with adult
splenocytes, a deficiency in this study that needs further investigation. Assuming that a
prozone effect had not occurred, these results were unexpected since Herman et al.
(1982) reported sensitization of offspring of Leishmania Jonovr/w-infected hamsters.
Lack of sensitization in our experimental progeny may also be a result of using a nonpathogenic, purified extract administered i.p.; Herman et al. (1982) administered live
amastigotes (active intracardiac infection) to their experimental animals.
Active infection is processed differently than an injection of soluble antigen from
a killed parasite. The life cycle of this parasite is complex and during the infection
process, promastigotes express abundant gp63 glycoprotein. On the other hand,
amastigotes (from which the extract was made) express very low levels of this protein
(Kurtzhals et al, 1994; Reiner & Locksley, 1995). The cytokine environment during
induction of immune responses to gp63 determine the course of disease resulting from
the type of immune responses induced (Kurtzhals et al, 1994; Reiner & Locksley, 1995).
Humoral responses are primarily induced by this protein (Kurtzhals et al, 1994) in the
early phase of infection, and Kemp et al (1994) showed that cytokine response in
visceral Leishmaniasis is primarily a Th2 response, whereas cutaneous Leishmaniasis
elicits predominantly Thl response. This suggests that there are different cytokine
environments in visceral versus cutaneous sites, and that response is also dependent on
route of administration (i.p. versus subcutaneous).
The unexpected result of these experiments may be rooted not only in the type of
antigen used to induce Th responses during pregnancy, but also the immunization
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program (dose, route, and timing; Zinkernagel & Kelly, 1997). In this dissertation, L.
major extract was injected i.p. and this may be a factor for lack of sensitization in
progeny, even though maternal spleens tested in vitro tended to a polarized Thl response.
Time of inoculation during pregnancy may be another factor; in a different model,
tolerization resulted when dams were inoculated 5-7 days antepartum (Beer et al, 1977).
In the current work, L. major extract was given 7 days antepartum, a time chosen as most
likely time to avoid fetal loss due to release of Thl cytokines (Krishnan et al., 1996b).
This single immunizing event may not have been sufficient to induce sensitization in
offspring, and may have induced tolerance. Sustained chronic immune responses to
Leishmania donovani over the whole course of pregnancy could explain sensitizations
realized by Herman et al. (1982).

Summary
The work presented in this dissertation clearly showed that there are characteristic
patterns in development of immune cell phenotypes and cytokine response capabilities.
Further, temporal characteristics of patterns in development may be dependent on genetic
background. Therefore, when evaluating immune parameters care must be taken to
choose an appropriate animal model and, at the very least, conclusions should entertain
the genetic component, a consideration of this study in using an outbred mouse model.
Results of experiments designed to clarify development of cytokine production by
neonatal cells showed that neonatal T cells are intrinsically capable of adult activity.
Most importantly, modulation of maternal immune status during gestation effected
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variations in development of immune parameters in progeny, alterations different than
those previously ascribed to presence of passive maternal antibody.

Future directions
Several of these findings challenge current tenets of developmental immunology
and warrant further exploration. Of merit is the finding that significant effects in
development can be induced during gestation, but a complete understanding of the
mechanism must be ascertained before elective manipulation can be entertained. Timing
and mode of delivering sensitizing or tolerizing immunogens must be defined, as well as
dose and schedule of immunization. Of considerable importance is the need to determine
what effect concurrent immune events would have on the intended process since
regulatory function promulgated by APC is subject to prevailing signals dictated by local
neuroendocrine immune products. Lastly, conditions in which transplacental passage of
maternal cells occurs need to be defined and then exploited to promote neonatal health.
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